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ABSTRACT
PROTEIN CHARGE ANISOTROPY MEDIATED SELF-ASSOCIATION AND PHASE
SEPARATION

SEPTEMBER 2015

DANIEL SEEMAN

Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST

Directed by: Professor Paul L. Dubin

Protein charge anisotropy results from the asymmetric distribution of charged residues
on the exterior of a particular protein. Interactions between proteins and other
macromolecules can be described in terms of attractive electrostatics; since electrostatic free
energies, at optimal I, are on the order of kT, it is unlikely that such associations would result
in desolvation, thus it is reasonable to consider such intermolecular attractions as being
mediated by hydrated protein surfaces. Such interactions can be broken down in terms of a
single protein interacting with a range of “binding partners”, including (1) protein-protein
interactions, (2) protein-polymer interactions, and (3) protein-surface interactions. Proteinprotein interactions can be divided into two types, self-interaction, where two monomers of
the same protein interact as is the case with either multimerization or aggregation; or
heteroprotein interactions where two different proteins associate, such as is seen with
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heteroprotein coacervation. Protein-polyelectrolyte (PE) interactions, have been shown to
result in formation of either soluble complexes, or in the case of protein-PE coacervation,
liquid-liquid phase separation (LLPS). The final case becomes useful when examining nonideal chromatographic behavior of proteins, where interactions between protein and
stationary phase can alter elution times, relative to those seen for the purely hydrodynamic
(or ideal) case. In all cases it is the hydrated protein that is key to such interactions.
The aggregation of model protein β-lactoglobulin (BLG) near its isoelectric point was
studied as a function of ionic strength and pH, where rates of aggregation were obtained
through a highly precise and convenient pH/turbidimetric titrations. A similar titration
procedure was used to obtain self-association rates of the more pharmaceutically relavent
protein, monoclonal antibody (mAb), at low temperature. Antibody (mAb) centrifuged at T <
0oC underwent LLPS upon thawing. The dense-phase was clearly identified, and a sharp
interface between mAb-enriched and mAb-depleted phases was confirmed. In cases where
LLPS was induced in the presence of a dye-labeled protein of opposite charge to mAb, the
two proteins were colocalized in the lower phase.
Heteroprotein coacervation of BLG and lactoferrin (LF) was examined by SANS and
rheology; the molar stoichiometry in coacervate has been reported to be LF(BLG2)2 assumed
to be the primary structural unit of the coacervate. Surface-bound water in protein solutions
was identified by a reduction in the heat of freezing of various coacervating systems, with a
specific focus on non-freezing water (NFW) in protein-protein (heteroprotein) coacervates.
These results are attributed to maximization of water-protein contacts, structural features that
reflect the mode of sample assembly, as they are not seen in a non-coacervated LF-BLG
solution with identical concentrations of all species.
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A method was developed in order to determine the yield and selectivity of
coacervates prepared from monoclonal antibody (mAb) and anionic polysaccharide
hyaluronic acid (HA). The yield of mAb, in such coacervates, is shown to be as high as 80%,
with final concentrations of MAb-A > 170 mg/mL; the yield of HA is ca. 75%; and a
selectivity ratio, S, of ca. 490 was obtained for coacervates prepared at pHc

BSA

< pH <

pHφmAb. Values corresponding to the start of complexation, and coacervation (pHc, pHφ) are
reported over a range of ionic strengths, I <200mM.
Monoclonal antibody (mAb), a protein with a highly patchy (or anisotropic) surface,
is shown to interact anomalously with chromatography columns at low I. Absolute molecular
weight (MW) determination vis-à-vis light scattering detection, suggests that late eluting
peaks, are larger in aggregation number than monomeric antibody. Such results suggest that
despite the lower apparent size obtained from column calibration, chemical degradation
cannot be responsible for these types of delayed elution volumes. This demonstrates the
importance of equilibrium controlled protein-protein and protein-surface interactions even in
single protein systems.
Protein self-interactions result in a type of LLPS with features similar to
coacervation, but over a much less restricted range of conditions. Heteroprotein-interactions
introduce a structural constraint that is reflected in a highly constrained set of conditions for
heteroprotein coacervation. Protein-PE coacervates can be formed over a much more
extended range of pH and I, possible due to the greater flexibility of the PE chain; and
finally, direct interactions with chromatography columns may involve attractive electrostatic
interactions, analogous to those seen in coacervating systems.
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CHAPTER 1
INTRODUCTION
1.1 Overview of Protein Electrostatics
Protein charge anisotropy results from the asymmetric distribution of charged
residues on the exterior of a particular protein, such that there exists a careful balance of
repulsive and attractive electrostatics, which controls interactions between like-charged
proteins near their isoelectric points (pIs). Such asymmetric charge domains, or protein
charge patches can facilitate attractive interactions between like-charged macromolecules
(e.g., protein-polyelectrolyte, and protein-protein complexes). Because protein–protein
interactions involve solvent-accessible surfaces, protein charge anisotropy is often a major
factor.1, 2

Figure 1.1: Representative charge anisotropy of three common model proteins; BLG; BSA;
insulin. Scale bar = 1nm.
!
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Protein charge anisotropy is a major component of both protein self-association, and
interactions with polyelectrolytes (PEs). Figure 1.1 shows electrostatic potentials of three
proteins: β-lactoglobulin (BLG), bovine serum albumin (BSA), and Zn-Insulin; screened
electrostatics are calculated using a program called DelPhi which provides solutions to the
nonlinear Poisson Boltzmann equation.3 Isopotential contours (grids of constant potential)
from such calculations are displayed at a cutoff of ±0.5 kT/e, where the electrostatic
potential, ψ, is expressed in terms of thermal energy, kT, per elementary charge unit, e. The
nonlinear Poisson Boltzmann equation is extremely useful for objects with arbitrary or
irregular geometries, such as proteins and many other macromolecules, where no simple
empirical models, based on geometry, exist.
Proper consideration of electrostatics requires an expression relating ionic strength (I)
to the falloff of electrostatic potential at some distance, r, from a protein surface. For
monovalent electrolytes, such as NaCl, I is directly equivalent to the molar concentration of
salt. The Debye length (κ-1) can then be calculated according to:
!!!!!!

(1.1)

This expression is in terms of the Bjerrum length (λB = 0.6nm in H2O) defined as the
distance over which an interaction between a pair of charges is equal to thermal energy, or
kT. This term, λB, absorbs all the temperature and solvent dependent terms, allowing for the
simplification of the entire expression to κ-1 = 0.304/√([NaCl]), which yields the Debye
length in units of nm.
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A

B

Figure 1.2: The Debye length, κ-1, functions as a decay constant controlling the (a) falloff of
an electrostatic potential, ψ(r), at a given distance, r, from a flat surface at I = 0.001, 0.025,
0.075, 0.150, and 0.500 M, with corresponding values of κ-1 = 9.6, 1.9, 1.1, 0.4, and 0.8 nm,
(b) the range of electrostatic interactions is controlled by addition of salt, with the most
dramatic effect at low (< 10 mM) salt, boxes correspond to regions of κ-1 greater than, similar
to, and less than protein size.
!
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By assuming a particular surface geometry (i.e., sphere, cylinder, or flat plane) it
becomes possible to explicitly calculate a surface potential, given a known charge density.
For the simple case, a flat surface of low surface potential, ψ0, the Poisson equation can be
solved explicitly, giving the result:

(1.2)

With, κ, simply being the inverse of κ-1, the Debye length. The result is that the
potential decays exponentially at increasing distance from the surface, r. As I is increased, κ
increases, meaning that the decay of the electrostatic potential with r occurs more rapidly,
decreasing the distance over which the potential extends from the surface.

Figure 1.3: Protein structure mediates electrostatic interactions, vis-à-vis placement of amino
charges. At intermediate I, the arrangement of charges results in the formation of charge
domains.
The effective length-scale over which electrostatic interactions, either attractive or
repulsive, can persist is controlled by ionic strength, via the effective screening length κ-1
(Figure 1.2B). The Debye length becomes extremely large in the limit of low salt, a condition
at which electrostatic interactions start to resemble bare (unscreened) coulombics. In the
case where κ-1 is on the order of the protein radius, the arrangement of acidic and basic
residues (Figure 1.3) results in the formation of well-defined charge domains, harder to
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define at very high, or very low I.
1.2 Measuring Protein and Amino Acid Charge
Charge asymmetry is visualized by electrostatic modeling based on protein sequence,
three-dimensional structure, and protein titration curves. In nearly all cases, the primary
sequence of a protein of interest is available; in many instances high-resolution protein
structures exist, and can be taken with minimal modification from the RCSB Protein Data
Bank (http://www.rcsb.org). The atomic coordinates of such proteins are usually obtained
from either X-ray diffraction, or from 2D-NMR; when no such information is available,
protein structures can be constructed via homology modeling, assuming that an adequate
level of sequence homology exists between the template and the protein whose structure is
being modeled. Knowing the location of each titratable side-chain allows for assignment of
amino acid charges on the basis the degree of dissociation of a particular residue.
This degree of dissociation (α) of a particular amino acid is generated using a method
based on the spherical-smeared-charge model proposed by Charles Tanford4 via iterative
refinement of protein charge curves (Figure 1.4), where such curves are obtained directly
from potentiometric titration. Such experiments allow for the charge state on a titratable
macromolecule to be obtained directly from the volume difference between blank and
experimental solutions, so long as titrants of precisely known molarity are used.
Using this smeared-charge model, the role of pH on perturbing α can be described by
an empirical electrostatic interaction parameter, w, the effect of which is controlled by total
protein charge, Z:
!!
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(1.3)

This expression allows for consideration of electrostatic repulsion among charged
amino acids, often resulting in perturbation of the intrinsic pK of a particular amino acid, an
effect that is amplified when the ionizable group is within a protein charge domain (Figure
1.1).

Figure 1.4: Total protein charge is calculated by summing the degree of dissociation, α, of
all acidic and basic amino acids, at a predefined set of pHs.
In order to couple electrostatic modeling with experimental measurements of protein
charge, an iterative method is used to extract accurate intrinsic pK values from
potentiometric titrations. Charge curves are calculated via the following summation:
!

(1.4)

Where Z is the charge of the ith amino acid side chain, based on the degree of
dissociation (α) calculated at a particular pH, n resi i is the total number of the ith type of
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amino acid, and Ztotal is the sum over all charged groups within a particular protein. A charge
curve can be generated by calculating Ztotal as a function of pH (Figure 1.4); these curves can
then be compared directly with experimentally obtained titration curves; each successive
iteration represents a new permutation of pKn and wn; therefore, this refinement allows us to
calculate the degree of dissociation of the nth amino acid, αn, using the experimental pH
dependence of Z as input.
1.3 Interest in Understanding Charged Interactions in Native Proteins
Open-ended self-association of compact globular proteins is of great importance in
the production, storage, and formulation of many biologically based pharmaceuticals. These
issues arise in predicting the stability of so-called classical protein drugs e.g., growth factors,
insulin, and insulin analogs at high concentrations.5, 6, 7 Until recently, the focus on protein
conformational diseases8 has led to a focus on interactions between unfolded, or partiallyunfolded, proteins. Denaturing aggregation, controlled by intrinsically short range
interactions, is frequently irreversible and highly protein-specific.9 On the other hand, selfassociation of natively folded globular proteins10 can be readily reversed by changing
solution conditions (e.g., pH11 or I12, 13). With the increase in production of biologics,
specifically focused on production of monoclonal antibodies (mAbs), new issues have arisen
with regard to protein stability against aggregation. In order to understand this kind of
unwanted self-association behavior, it becomes necessary to consider protein-protein
interactions between native proteins. In the case of native protein aggregation, such
interactions are between two or more monomers of the same protein.
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Figure 1.5: Fractal dimensions can be used to determine the density of aggregates assembled
from well-defined, colloidal particles.14
Any attempt to correlate electrostatic effects with protein charge anisotropy, in the
context of the kinetics of protein aggregation must account for the mechanism of
aggregation.15 Consumption of free monomeric protein via addition to preformed protein
aggregates should be controlled by the structure of such aggregates.16 Comparison of such
structures to those described by simple colloidal models (i.e., diffusion or reaction - limited
aggregation processes) can reveal information about the mechanism of self-association
(Figure 1.5). Equilibrium solution behavior is typically seen at high salt, I ≥ 0.15 M where
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electrostatic interactions are largely screened at all but short protein-protein separation
distances, and at pH far from protein pI where the attractive force responsible for kinetically
controlled aggregation of native protein is typically minimized.
Turbidimetric measurements17, 18, 19 are often used to relate aggregation kinetics to pH
dependent solution behavior, using pH titrations. Such measurements are made on largely
transparent solutions, where the “turbidity” being measured is in fact derived from a
measurement of transmittance, measurable up to ±1 ppt. These turbidimetric titrations are
sensitive to very small changes in the intensity of scattered light, measured as the % of
transmitted light lost to scattering at all non-zero scattering angles. In such experiments,
turbidity is expressed as 100 - %T, which is linear with classical turbidity τ in the limit of
low turbidity. These titrations are capable of detecting small increases in τ resulting from
increase in aggregation number (monomer, dimer, etc.) and also complexation, as well as
gross increases in turbidity due to aggregation, phase separation, and droplet formation. The
later phenomenon are frequently seen in systems involving either heteroprotein interactions
or protein-PE interactions.

1.4 Hydrated Protein Surfaces Mediate Numerous Intermolecular Interactions
Interactions between proteins and other macromolecules can be described in terms of
attractive electrostatics; since such electrostatic interactions are on the order of kT, it is
unlikely that such associations would result in desolvation; thus it is reasonable to consider
such intermolecular attractions as being mediated by hydrated protein surfaces.
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Figure 1.6: Typical grainy appearance of a suspension of coacervate droplets, as seen during
a turbidimetric titration. Note graininess is due to the presence of stable droplets with a
unique set of refractive indices, and of a characteristic size.
These types of interactions can include a single protein interacting with a range of
“binding partners”, including (1) protein-protein interactions, (2) protein-polymer
interactions, and (3) protein-surface interactions. Protein-protein interactions can be divided
into two types: self-interaction, where two monomers of the same protein interact, as is the
case with either multimerization or aggregation; or interactions where two different proteins
associate, such as is seen with heteroprotein coacervation. The second case, protein-PE
interactions, where a compact electrostatically complex binding partner has been replaced by
a flexible polymer of high (but uniform) charge density, has been shown to result in
formation of either soluble complexes, or in the case of protein-PE coacervation, liquidliquid phase separation (LLPS). In all cases it is the hydrated protein that is key to such
interactions.
1.5 Complex Coacervation
Complex coacervation is a unique form of LLPS that results from non-specific attractive
electrostatic interactions between oppositely charged macromolecules;20 such coacervates
(Figure 1.6) can be prepared from a number of precursors. Self-association of globular
!
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proteins can in some cases result in equilibrium controlled LLPS, although it is not clear to
what extent this is analogous to coacervation, as there is a single precursor protein. The case
for two different proteins, referred to as heteroprotein coacervation, occurs under a very
narrow range of solution conditions, even when the proteins remain oppositely charged over
a wide range of pHs and Is. When one of the proteins is replaced by a flexible
polyelectrolyte, coacervation can occur over a much wider range of conditions, and
interactions often begin at pHs where the protein and PE are of like charge, pH > pI for
polyanions or pH < pI for polycations, such cases termed “binding on the wrong side of pI”.
Interactions with surfaces such as chromatography packing particles, while also
equilibrium controlled, and in many cases also involving patchy interactions between
particles and proteins of like-charge, are likely too different in form from the above cases to
be effectively compared to coacervating systems, although the formation of soluble
complexes may be a useful analogy in this case.
1.6 Overview
Protein self-interaction can result in a type of LLPS with features similar to
coacervation, but over a much less specific set of conditions. Heteroprotein-interactions
introduce a level of geometric constraint that is reflected in a highly constrained set of
conditions for heteroprotein coacervation. Protein-PE coacervates can be formed under a
much more extended set of solution conditions, possible due to the flexibility of the PE
chain; and finally, non-ideal interactions in chromatography may involve attractive
electrostatic interactions, involving protein charge patches, analogous to those seen in
coacervating systems.
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CHAPTER 2
pH-DEPENDENT AGGREGATION AND DISAGGREGATION OF NATIVE βLACTOGLOBULIN IN LOW SALT
Yunfeng Yan, Daniel Seeman,* Bingqian Zheng, Ebru Kizilay, Yisheng Xu, and Paul L.
Dubin * Langmuir, 2013, 29 (14), pp 4584–4593
*

corresponding author

2.1 Abstract
The aggregation of β-lactoglobulin (BLG) near its isoelectric point was studied as a
function of ionic strength and pH. We compared the behavior of native BLG with those of its
two isoforms, BLG-A and BLG-B, and with that of a protein with a very similar pI, bovine
serum albumin (BSA). Rates of aggregation were obtained through a highly precise and
convenient pH/turbidimetric titration that measures transmittance to ±0.05 %T. A
comparison of BLG and BSA suggests that the difference between pHmax (the pH of the
maximum aggregation rate) and pI is systematically related to the nature of protein charge
asymmetry, as further supported by the effect of localized charge density on the dramatically
different aggregation rates of the two BLG isoforms. Kinetic measurements including very
short time periods show well-differentiated aggregation steps. BLG was analyzed by light
scattering under conditions corresponding to maxima in the first and second steps. Dynamic
light scattering (DLS) was used to monitor the kinetics, and static light scattering (SLS) was
used to evaluate the aggregate structure fractal dimensions at different quench points. The
rate of the first step is relatively symmetrical around pHmax and is attributed to the local
charges within the negative domain of the free protein. In contrast, the remarkably linear pH
dependence of the second step is related to the uniform reduction in global protein charge
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with increasing pH below pI, accompanied by an attractive force due to surface charge
fluctuations.

2.2 Introduction
The aggregation of proteins in their native state, an effect predominant at low ionic
strength and pH near pI, is a reflection of their surface properties, in particular, the
distribution of charged domains. In contrast to unfolding aggregation, native state
aggregation involves interactions among hydrated protein surfaces. Without the exposure of
solvophobic groups, the aggregation rate does not depend on the kinetics of an array of
transient intermediates and exhibits a higher degree of reversibility. To the extent that the
limited states involved in the aggregation process are well defined, the aggregation kinetics
can be analyzed from the perspective of energetics. Surface charges and their distributions
then become the focus of interprotein and interparticle interactions. The diminished role of
primary structure means that the aggregation of folded proteins is less protein-specific, and
predictive rules based on protein tertiary structure and charge anisotropy are possible.
The association of folded proteins is of considerable importance for pharmaceutical
formulation stability5, 6, 7 and is likely to influence subsequent behavior under more extreme
conditions. However, current concerns about protein conformational diseases8 have led to a
focus on the irreversible association of unfolded precursors. Unfolding aggregation requires
the disruption of secondary or tertiary structure and therefore the disturbance of the
numerous hydrophobic and hydrogen-bonding interactions that stabilize the native state.
Proteins with various primary structures show different aggregation mechanisms, manifested
in a variety of intermediates, aggregate structures, and critical temperatures. Because
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different regions of the protein surface become exposed and engaged in short-range
interactions, unfolding aggregation can be irreversible and the mechanisms can also be
highly protein-specific.9 The corresponding numerous forms of denaturing aggregation have
led to several attempts at aggregation classification – with some referring to the mechanism
and some referring to the size, morphology, and reversibility of aggregates.8 However, no
general rules can be proposed to relate the sequence arrangement to the unfolding
aggregation behavior, which is often observed to occur irreversibly, particularly under
extreme conditions.
The characteristic reversibility of aggregation in the native state arises from the
absence of high-energy unfolded intermediates subject to a new set of short-range
interactions.10 For intrinsically reversible native state aggregation,11 the interactions involved
can be better understood as involving only the hydrated protein surface.21 Interprotein
interactions may be resolved into enthalpic and entropic contributions,22 in a way almost
impossible when subject to ongoing protein conformational changes.22 The fact that native
state aggregation, isoelectric precipitation, is suppressed by salt reveals the electrostatic
origin of these contributions and suggests considerations of protein charge anisotropy.12, 13
Protein charge anisotropy is characterized by an asymmetric distribution of charge domains
on a protein such that there are similar magnitude repulsive and attractive interactions present
between like-charged proteins near the pI. Such charge patches are necessary to explain
instances of attractive interactions between proteins and PEs observed on the “wrong side” of
the isoelectric point for which neither net charge nor highly short-range interactions would
provide an adequate explanation.23
Electrostatic interactions among native proteins govern both the aggregation process
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and the structure of the final aggregate. When self-association involves electrostatic
interactions, their long-range nature means that spatial separation, the first step of
disaggregation, can be accomplished through changes in pH and ionic strength without
exposure of hydrophobic residues. Resolvation, screening by small ions, or repulsive forces
arising from changes in pH then compensates for the loss of interprotein attractive forces.
Those pairwise interactions can be defined at specified conditions of pH, ionic strength, and
temperature.24 Resolution into enthalpic and entropic contributions25 is possible when the
initial and final states are well-defined and kinetics do not dominate. Modeling can then help
to predict the geometry of multimers and to resolve equilibrium association constants for
cognate protein–protein interactions into kon and koff.26,

27

Because protein–protein

interactions involve solvent-accessible surfaces, protein charge anisotropy is often a
contributing factor.1, 2
The role of charge anisotropy in native state aggregation is revealed by the tendency
of proteins to become insoluble at pH near the isoelectric point.28 Because the net charge is
near zero, electrostatic attractions can come only from charge asymmetry that can be
visualized by computational methods based on protein structure (from the RCSB Protein
Data Bank) and protein charge curves.23 However, the correlation of protein charge with
aggregation kinetics must take into account the mechanism of aggregation and deal with
simultaneous equilibrium and kinetic behavior where subsequent steps governed by transient
intermediates may be rate-determining.15 Clustering or later-stage monomer consumption can
be influenced by the structure of aggregates, the assembly of which is conveniently described
by fractal dimensions.16 In addition, later stages of aggregation prior to irreversible
association can be subject to hysteresis because competing disaggregation may proceed by a
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different pathway.29,

30

Nevertheless, strong evidence of correlations between the protein

surface charge state and native state aggregation rates prior to loss of solubility has been
gleaned from turbidimetric measurements.31, 32, 33 β-lactoglobulin (BLG) with two isoforms
that differ with respect to a charge patch should provide an example of such behavior.31
The aggregation of BLG has probably been studied more than that of any other
protein. The great majority of these studies have involved denaturing conditions34, 35 (e.g.,
extremes in pH or temperature because of their relevance to food and dairy processing36, 37).
The heat-induced aggregation of BLG is sometimes used as a general model for fibril
formation,38, 39 a process that is implicated in neurodegenerative diseases.40 Although many
papers on denaturing aggregation focus on kinetics,41,

42

studies of the native state

aggregation of BLG mainly deal with the equilibrium association of multimers or oligomers.
Major findings include (1) the formation of dimers in equilibrium with monomers at 3 < pH
< 943, 44, 45, 46 enhanced by increasing ionic strength I46, 47, 48, 49 and (2) the formation of
higher-order multimers at pH 4 to 5, which for the case of an octamer48, 50, 51, 52 shows an
opposite ionic strength dependence, shifting toward the dimer with added salt, but other
reports suggest that the tetramer and hexamer could coexist.53 Such equilibrium behavior
seems to be typical for BLG at I ≥ 0.1 M at pH far from its pI, where open-ended aggregation
is avoided, although the distinction between multimerization and aggregation becomes less
clear when the products of the association are small (e.g., clusters containing relatively small
numbers of proteins54).
Kinetically controlled aggregation of BLG in the native state is typical at I < 0.01 M,
especially at pH near pI. Kumosins et al.53 concluded from sedimentation kinetics that the
aggregation of BLG is the sum of three possible interactions, namely, A–A and B–B self-
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interactions and A–B interactions. Timasheff and Townend55 expanded on this, concluding
that the aggregation of BLG is due primarily to a single isoform, namely, BLG-A. Majhi et
al.31 found two processes: an initial fast consumption of the BLG dimer to form an aggregate
of intermediate size, followed by slow growth of the aggregates. The maximum aggregation
rate occurred near pH 4.6, below the pI of 5.2, and the pH dependence of the initial
aggregation rate was highly asymmetric. At pH 5.0, the initial rate increased with 1/I. This
open-ended aggregation at pH ≠ pI was attributed to the charge anisotropy of native BLG
that was visualized by computer modeling. Such visualization was used to explain the
dramatic effect on the aggregation rate when residues in BLG-B (Gly64, Ala118) are
replaced in BLG-A (Asp64, Val118). However, the nature of the proposed two-step
mechanism was not clearly elucidated, and little attention was paid to the role of pHdependent disaggregation.
Here we consider the mechanism of pH-induced BLG native state aggregation in the
vicinity of pI, with particular attention to two factors not previously examined: (1) the strong
effect of the direction of pH adjustment on both aggregation and disaggregation kinetics, and
(2) the nature of the two characteristic rate processes and their relationships to net versus
local protein charge.48, 51 We used turbidimetric pH titrations as a convenient and effective
method for measuring aggregation rates as a function of pH and the time dependence of
turbidity to resolve and quantitate pH effects on the two rates. Dynamic light scattering
(DLS) was used to evaluate the kinetics in terms of hydrodynamic diameters and scattering
intensity under conditions where the two steps are easily resolved as revealed from titration
experiments. Static light scattering (SLS) was employed to evaluate the fractal structure of
quenched aggregates at two pH values corresponding to maximum values of the two rates.
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Electrostatic protein modeling was employed to support two distinct molecular descriptions
for these processes. Finally, we show the broad and general significance of these approaches
with reference to BSA as an example of protein with charge anisotropy distinct from that of
BLG.

2.3 Experimental Section
Materials. Native bovine β-lactoglobulin (BLG, 18 kDa, pI = 5.2) was a gift from C. Schmitt
(Nestlé, Lausanne; >97%, batch number JE 001-8-415, 55.4% BLG-A and 41.6% BLG-B).
Isoforms of BLG (BLG-A and BLG-B) were from Sigma-Aldrich (lot nos. 097K7010 and
048K7003 V, respectively). Fatty acid-free bovine serum albumin fraction V (BSA, 68 kDa,
pI = 4.9, >99%) was Calbiochem lot D00096763. NaCl and standard NaOH and HCl
solutions were purchased from Fisher Scientific. Milli-Q water was used in all sample
preparation.
Turbidimetric Methods. Turbidimetric titrations were performed by the addition of either
0.1 N NaOH (forward titration) or 0.1 N HCl (backward titration) to a 15 mL protein solution
with stirring and the simultaneous monitoring of pH and transmittance at 25 °C. It is
conventional to report turbidity (τ) as 100 – %T, a unitless quantity that is linear with
turbidity over a certain range of transmittance. It is convenient to describe it in this form
because it absorbs terms such as the extinction coefficient, which would otherwise be poorly
defined for such systems. The rate of pH change was kept at 0.2 pH units/min in all titrations
except for the experiments in Figure 2.11. For kinetic experiments, protein solutions were
prepared at pH 9 and brought to the desired pH by the addition of 0.1 N HCl in 15 s. The
transmittance of protein solutions was measured using a Brinkmann PC 800 colorimeter
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equipped with a 420 nm filter and a 1 cm path length fiber optic probe, calibrated to 100%
transmittance with Milli-Q water. Instrument drift during a single measurement was less than
0.05 %T after a 30 min warm-up. pH was measured with a Corning 240 pH meter. Samples
were filtered with a 0.22 µm membrane (Millipore) before titration. With this technique,
turbidity measurements are precise to ±2 ppt and highly robust, with repeatability
demonstrated by the precise reproduction of the I dependence of BLG aggregation rates
previously measured31 (Figure 2.13).
Dynamic Light Scattering (DLS). DLS was carried out at 25.0 °C with a Malvern Zetasizer
Nano ZS instrument equipped for backscattering at 173° with a 633 nm He–Ne laser. Protein
solutions were adjusted rapidly from a nonaggregating pH 7.0 to pH 4.9 or 5.1. DLS
measurements were started within 30 s of the pH adjustment. The distributions of the mean
apparent translational diffusion coefficients (DT) were determined by fitting the DLS
autocorrelation functions using non-negative constrained least-squares (NNLS). The
robustness of this algorithm vis-à-vis CONTIN has been amply demonstrated, even for
systems with more than two decay modes. The distribution of the apparent hydrodynamic
radii (Rapp) was obtained from the distribution of mean apparent translational diffusion
coefficients (DT) via

Rapp = kT/6πη DT

(2.1)

where k is the Boltzmann constant, T is the absolute temperature, and η is the solvent
viscosity, which was assumed to be that of water.
Static Light Scattering (SLS). SLS experiments were performed using a BI-200 SM
goniometer and BIC-2030D photon counting system (Brookhaven Instruments Inc.) with an
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Omnichrome Ar ion laser (100 mW, λ = 488 nm) at ambient temperature, ∼25 °C. The
scattering intensity was measured as a function of scattering angle between 75 and 120°.
Fractal dimensions (Df) were extracted from angle dependence in the high-q limit via
linearization56 of the scattering data using the relation

I(q) ∝ q –Df

(2.2)

where I(q) is the scattering intensity and the scattering vector q is (4πn/λ) sin(θ/2), with n the
refractive index of the fluid, λ the wavelength, and θ the scattering angle. BLG aggregation
in 0.01 M NaCl was initiated by pH adjustment from 7.0 to either 4.9 or 5.1 and sustained for
5–20 min. Aggregation was quenched by rapid adjustment from the aggregating pH to pH
4.4, at which point the aggregate size was found by DLS to no longer change with time. Each
SLS measurement was made in replicate over the course of 2 h to ensure that quenched
samples were invariant with respect to time.
Computational Methods. DelPhi3 V. 4r1.1 was used to model the electrostatic potential
around the protein as a function of pH and ionic strength. PDB 3V03 (BSA monomer) and
1BEB (BLG dimer) were taken from the RCSB Protein Data Bank (http://www.rcsb.org).
The amino acid charges were generated using the spherical-smeared-charge model proposed
by Tanford on the basis of titration curves of BLG and BSA.4

2.4 Results
2.4.1 Turbidimetric pH Titrations
The increase in turbidity upon addition of acid or base, as shown for the curve of
larger magnitude in Figure 2.1A, summarizes the accumulation of soluble aggregates and
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their subsequent redissolution with diminishing pH. Even at fixed protein concentration and
ionic strength, the turbidity, as a kinetic variable, is sensitive to the elapsed time between
titrant increments, which is presumably responsible for deviations in absolute turbidity
among duplicate runs; this did not exceed 15% (relative). However, the pH corresponding to
the maximum change in turbidity (dτ/dt)max did not vary. The rate of titrant addition was
controlled to ensure that dpH/dt is constant; consequently, the instantaneous rate of
aggregation at any pH ((dτ/dt)pH) is given by (dτ/dpH)(dpH/dt). Hence, the plot in Figure
2.1B essentially describes the pH dependence of the instantaneous rate of aggregation. As
will be shown below, (dτ/dt)pH obtained in this way is remarkably similar to (dτ/dt)t=0 at fixed
pH so that the inflection points indicated by the vertical dashed lines are the pHs of the
maximum aggregation rate. It is of interest to note the crossing point of the two curves in
Figure 2.1A, which correspond closely to the identical pH positions of the maxima in Figure
2.1B. The absence of any effect of the titration direction on the rate at this point suggests that
the process is controlled by free protein and not prior aggregates. Furthermore, the pH values
at the turbidity maxima can be directly confirmed as conditions of constant turbidity (Figure
2.12 in the Supporting Information). The magnitude of accumulated aggregate τmax clearly
depends on the direction of titration (Figure 2.1A). This may indicate differences in
aggregate structure, which also would lead to differences in disaggregation. However,
regardless of the titration direction, the curves cross at the inflection point (see also dτ/dpH
in Figure 2.1B): the maximum aggregation rate occurs at the same pH.
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Figure 2.1: (A) Type 1 titrations of 1.0 g/L BLG in 0.0045 M NaCl. (B) dτ/dpH vs pH. The
rate of addition of HCl or NaOH was 0.2 pH unit/min. The titration directions indicated by
arrows are (□) low to high pH and (○) high to low pH. The vertical dashed line corresponds
to the inflection points (maximum aggregation rates) for both directions. −dτ/dpH is shown
for pH 9 → 3 to adjust for the trivially negative values of dpH: negative values in (B)
correspond to disaggregation.
To demonstrate the utility of turbidimetric pH titrations, we carried out titrations with
acid at ionic strengths I ranging from 0.0045 to 0.1 M (NaCl). The ionic strength dependence
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–1

of the inflection points (dτ/dpH)max showed nearly the same I dependence (Figure 2.13) as
seen previously for the initial rate at fixed pH (dτ/dt)0.31 As expected, the maximum turbidity
depended on the rate of titration, increasing ca. 40% with a 3-fold decrease in (dpH/dt), but
the characteristic pHs of τmax and (dτ/dt)max (figure 2.11) were independent of (dpH/dt). The
pH titrations thus yield, more conveniently, very similar results to the more laborious timedependent studies at fixed pH.

2.4.2 Identification of Two Steps
The extent of aggregation of BLG increases with pH from 4.4 to 4.8 and decreases as
the pH increases from 5.1 to 5.7 (Figure 2.2), but the pH dependence of the amount of
aggregate is seen to be mainly determined in the first ca. 10 min. In other words, a fast initial
step is followed by a slow second step. The pH dependences of the aggregation rates for the
fast initial step (t < 10 min) and the following slow step (45 < t < 90 min) are reported as
(dτ/dt)0 and (dτ/dt)2 in Figure 2.3A and B, respectively. The pH dependence of (dτ/dt)0 is
symmetric around a maximum at pH 4.9 (i.e., below pI = 5.2). In contrast, (dτ/dt)2, typically
ca. 25 times smaller than (dτ/dt)0, is remarkably linear with pH, attaining a maximum at pI.
In addition, the two steps show different ionic strength dependences (i.e., the aggregation rate
is linear with I

–1

for the initial step and with I

–0.25

for the second step (Figure 2.4)). The

implications regarding the different mechanisms and the respective roles of protein charge
anisotropy in the two steps will be discussed below.
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Figure 2.2: Turbidity vs time for 1.0 g/L BLG (1.3:1 A/B), I = 0.0045 M (A) pH 4.4–4.8 and
(B) pH 5.1–5.7.
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Figure 2.3: Aggregation rate (dτ/dt) vs pH from Figure 2.2. (A) Initial rate (dτ/dt)0 and (B)
aggregation rate for the second step (dτ/dt)2. The vertical dashed lines denote the pHs for the

maxima of (dτ/dt)0 and (dτ/dt)2. Note the different scales for plots A and B showing the
dominant effect of the initial rate.
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Figure 2.4: Logarithmic plot of dτ/dt and I (open symbols for the initial rate, filled symbols
for the second step) at pH 5.0. The slopes are −1 and −0.25 for (dτ/dt)0 and (dτ/dt)2,
respectively. Data are reproduced from a previous paper.31
2.4.3 Structure of BLG Aggregates
Dynamic light scattering (DLS) was used to study the aggregation of 1.0 g/L BLG at
pH 4.9 and 5.1, conditions that correspond to the apparent aggregation rate maxima in the
initial and second steps, respectively. At pH 4.9, where the initial rate dominates,
hydrodynamic diameters (Figure 2.5A) grow to over a micrometer in t < 10 min, during
which time the scattering intensity increases dramatically (Figure 2.5C). In contrast, at pH
5.1, a gradual increase in size is observed (Figure 2.5B) along with an almost negligible
increase in scattering intensity (Figure 2.5D). The increase in diameters seen at pH 4.9 at
short time together with the relatively smaller effect at pH 5.1 suggests that the initial rate is
!
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controlled by the formation of nuclei, and the second step involves the growth of preformed
nuclei. Notably absent is any evidence of species of intermediate size, indicating that
aggregates are formed from BLG dimers (possibly in equilibrium with monomers) with no
involvement of multimers such as tetramers and hexamers.

Figure 2.5: DLS kinetics of 1.0 g/L BLG in I = 0.01 M at (A, C) pH 4.9 and (B, D) pH 5.1.
(○) Slow mode and (□) fast mode obtained from the intensity-weighted distribution of
apparent diameters. The inset in plot A is an expansion of the first 13 min.
The apparent quenching of aggregate growth (Figures 2.1B and 12) arises from a
balance of aggregation and disaggregation rates at a particular pH (i.e., 4.4). Adjustment
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from aggregating conditions (pH 4.9 or 5.1) to this quenching condition halts the growth of
protein aggregates. SLS results under these two conditions are shown in Figure 2.6. Fractal
dimensions, a power law describing the distribution of mass or scattering centers within an
aggregate, were measured for each quenched sample.
SLS results for the sample quenched from pH 4.9 (Figure 2.6A) where step one is
maximal show that the apparent Df of BLG aggregates increases continuously before finally
converging to a limiting value of 3.0, which is consistent with a fully compact structure. At
pH 5.1 (Figure 2.6B), the increase in fractal dimension is comparable but a lower limiting
value is reached, indicating that these aggregates remain somewhat fractal in nature even at t
= 20 min (Figure 2.6C). The Df increases slowly during the first ∼10 min, a lag time
displayed at both pHs. In this first step the structures formed are loose, allowing for the rapid
packing of free BLG into the aggregate. The values of Df would seem to preclude both
classical diffusion- and reaction-limited cluster–cluster aggregation14 but are consistent with
an initial nucleation step represented by diffusion-limited particle–cluster aggregation.14 By
the final quench point, aggregates are no longer fractal in nature, possibly explained by a
switch to reaction-limited particle cluster aggregation14 in which the close packing of free
protein results in a nearly homogeneous structure. At pH 5.1, such nucleation occurs more
slowly, leading to a smaller observed fractal dimension at the final quench point.
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Figure 2.6: SLS of 1 g/L BLG in I = 0.01 M quenched by adjustment to pH 4.4 after a fixed
amount of time. BLG aggregation is induced at (A) pH 4.9 and (B) pH 5.1. (C) Apparent Df
as a function of quench time.

In the absence of intermediate species (e.g., oligomers), the increase in turbidity must
be attributed to the formation of aggregates that grow in size and decrease in number. With
appropriate assumptions about their density, based on fractal dimensions, it is possible to
4

6

estimate that the number of dimers per aggregate increases from roughly 2 × 10 to 5 × 10

over the first 20 min, with a concomitant 250-fold decrease in the number of aggregates. The
present results do not indicate whether this occurs by aggregate fusion or dimer consumption,
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which is the subject of an ongoing size exclusion study.
2.4.4 Aggregation of BLG Isoforms
The marked difference between the amplitudes of aggregation of BLG variants A and
B provides strong evidence of the effect of charge anisotropy that arises from the
replacement of uncharged amino acid glycine by aspartic acid in BLG-A, adding two
additional negative charges per dimer, as previously noted.57 Native BLG can be found under
dimer dissociation conditions,31 to contain roughly equal numbers of the A and B monomers,
but the distribution among the three possible dimers is not always clear. Mass spectra of
Sigma BLG-A prepared at pH 4.5 showed unresolved dimer peaks,58 but more recently
obtained higher-resolution spectra (Figure 2.14) suggest that the AA and BB dimers that
predominate in native BLG may dissociate to form the AB heterodimer. This complexity
provides additional motivation to examine the aggregation behavior of the homodimers.
Turbidimetric pH titrations of AA and BB are shown in Figure 2.7A,B. Regardless of
the direction of titration, aggregation rates are larger by factors of 20–30 for the A dimer. For
both titration directions, the aggregation of BLG-A begins only at pH within 0.5 pH unit of
the pI. For titration with base, significant disaggregation commences at pH 7.5, and for
titration with acid, at pH 3.5. The equivalence of crossing points with points of maximum
aggregation rate noted in Figure 2.1 is notably absent in Figure 2.7B because of the large
difference in rates. Further comparisons of BLG-B with BLG-A are complicated by the
different magnitudes mentioned above.
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Figure 2.7: Type 1 titrations and dτ/dpH vs pH for (A) 0.5 g/L BLG-A and (B) 0.5 g/L BLGB. The rate of addition of HCl or NaOH was 0.2 pH unit/min. The dashed line corresponds to
the pH of the maximum aggregation rate, independent of direction. Titration direction: (□)
low to high and (○) high to low. I = 0.0045 M. We show −dτ/dpH to adjust for the trivially
negative values of dpH for pH 9 → 3 in the lower curves.

2.4.5 Turbidimetric pH Titration of BSA
BLG aggregates most strongly at pH < pI where it is net positive charged because of
its negative charge patch.31 Because BSA, in contrast to BLG, has a positive charge patch,23
comparative titrations were done with BSA to reinforce this relationship with protein charge
anisotropy. The results of this type 1 titration for BSA in Figure 2.8 may be compared to the
analogous plot for BLG in Figure 2.1. As is the case for BLG, the pH for the maximum
aggregation rate of BSA does not depend on the titration direction, but in contrast to BLG,
the pHmax for BSA (5.4) is well above its pI (4.9).
!
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Figure 2.8: (A) Type 1 titrations of 1.0 g/L BSA in 0.0045 M NaCl with NaOH or HCl
(arrows). (B) dτ/dpH vs pH. The rate of addition of HCl or NaOH was 0.2 pH unit/min. The
titration directions indicated by arrows are (○) low to high pH and (□) high to low pH. The
vertical dashed line corresponds to the inflection points (maximum aggregation rates) for
both titration directions. −dτ/dpH is shown for pH 9 → 3 in plot B to adjust for the trivially
negative values of dpH.
2.5 Discussion
2.5.1 Forward and Backward pH Titrations
Turbidimetric pH titration is a convenient method for the study of electrostatically
driven native protein aggregation, particularly when the titration rate (dpH/dt) is constant.
The instantaneous aggregation rate (dτ/dt)pH at any pH is then obtained by (dτ/dpH)(dpH/dt).
For example, with dpH/dt = 0.2 pH unit/min, we obtain from the acid titration in Figure 2.1B
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–1

an aggregation rate of 4.0 %T min . The kinetic measurement at pH 4.8 (Figures 2.2 and
–1

2.3) gives the initial rate of dτ/dt = 4.1 %T min . The validation of this method was also
confirmed by the ionic strength dependence of the aggregation rate from turbidimetric pH
titration at varying I (Figure 2.13), similar to previous results.

31

The inflection points in

Figure 2.1 correspond to the pHs of the maximum aggregation rate, and the turbidity maxima
correspond to pH values at which turbidimetric rates of association and dissociation are equal
(Figure 2.12). These observations should apply generally to the pH dependence of native
state protein aggregation.
2.5.2 First Aggregation Step
The crossing point at pH 5.0 in Figure 2.1 shows the importance of the direction of
titration but also indicates a condition at which the rate of aggregation is independent of the
sample history. The strong influence of titration direction is in contrast to previous reports of
pH-induced aggregation, for instance with Zn-free insulin that appears to be essentially
reversible.59 The nearly symmetrical behavior in that case (titration curves did not cross) was
related to the dipole-like behavior of the protein, with high- and low-pH deviations from pI
essentially leading to charge mirror images. The dramatically different shapes of low-to-high
and high-to-low curves indicate important effects of the surface charge distribution not
reflected in |pH – pI|. However, the pHs at maximum dτ/dt (5.0) are independent of direction,
because they reflect only rates of change regardless of prior accumulations of aggregate and
thus depend uniquely on the state of the free protein. This point is 0.2 pH unit below pI; this
and the marked difference in aggregation rates for BLG-A and BLG-B31 suggest an
important role for the negative patch of BLG (Figure 2.9) wherein reside the additional two
Asp residues of the A dimer. The variation of the charge in this domain accounts for the pH
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dependence of aggregation, which is seen in Figure 2.3A to arise mainly from the first step.
The impact of this first step can be understood from charge anisotropy: the onset of
aggregation at pH ∼4.6 for base titration in Figure 2.1A corresponds to a large positive
domain (Figure 2.9C) capable of interacting with the negative domains of several others,
resulting in an open aggregate with a lower fractal dimension.60 A diffusion-limited analysis
of this process31 was shown to account for the I

–1

dependence of the initial rate shown in

Figure 2.4. Acid titration commencing at pH ∼5.4 shows less asymmetry, which could lead to
a more dense structure possibly producing higher turbidity (Figure 2.1A). Although the
structure of the aggregate formed may depend on the direction, the state of free protein that
determines the rate of the first step does not.

Figure 2.9: Electrostatic potential contours (+0.5kT/e (blue) and −0.5kT/e (red)) around the
BLG dimer at ionic strength 0.0045 M. pH values and corresponding net charges: (A) 4.0,
+12, (B) 4.4, +7, (C) 4.6, +6, (D) 4.8, +5, (E) 5.0, +3, (F) 5.2, 0, (G) 5.4, −2, and (H) 5.8, −3.
Calculation was based on pdb id 1BEB, which has the same arrangement (and number) of
charged residues as BLG B but has an additional noncharged amino acid. The scale bar is
equal to 1 nm. Dimer net charge61 rounded to the nearest whole number.
2.5.3 Second Aggregation Step
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In marked contrast to the behavior of the first step, we see for (dτ/dt)2 Figure 2.3B,
aggregation behavior that is highly asymmetric with respect to pH, with a local maximum at
pI, and a remarkably linear pH dependence of dτ/dt at lower pH. This linearity is consistent
with the linearity of net protein charge Z with pH in this region,61 along with maximum
aggregation at pH = pI, this suggests that global charge, not anisotropy, is dominant. As seen
in Figure 2.4, the diminution of (dτ/dt)2 with added salt also implies an electrostatic attractive
force, even at pH = pI. However, (dτ/dt)0 shows a stronger ionic strength dependence,
–1

increasing with I . This proportionality was previously explained31 as a consequence of an
increase in the target area of the protein negative domain with the square of the Debye length
–1

κ , which leads to the observed I
–1

(where the units of κ

–1

–1

dependence because for 1:1 electrolytes κ

and I are nm and M). (dτ/dt)2, however, depends on I

≈ 0.3/I

–0.25

1/2

. Because

free protein is consumed before the second step, it is necessary to identify a weakly screened
attractive force between clusters of low net charge. The theory by Miklavic for
inhomogeneously charged surfaces at short separation describes an attractive force that
becomes dominant when charges can migrate.62, 63 With any aggregating system, diffusion
will eventually induce microscopic concentration fluctuations that will bring two particles to
the short separation distances at which such theory becomes very relevant. The overall
2

attraction in this treatment increases with intercharge spacing and decreases with κ , the first
term dominating for low salt. To this effect we add a weak Z-dependent repulsion that
decreases with increasing κ (i.e., increasing I). The relative magnitudes of these two
opposing effects depend on the intercharge spacing of the cluster surface, which is not
known, but the observed I
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dependence of the attraction reflects their sum. The treatment
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of Miklavic et al. suggests that a balance between attraction and repulsion dictated by charge
spacing on the surface of protein clusters could lead to the observed I dependence. In
summary, protein net charge Z provides a weak repulsion, and its disappearance at pH 5.2
accounts for the maximum in (dτ/dt)2 in Figure 2.3B. The mobility of protein charges on the
cluster surface accounts for the attractive force that drives cluster–cluster association, in
contrast to the fixed charges on the nonaggregated dimer that control the first step.
2.5.4 BLG-A and BLG-B
The influence of protein charge anisotropy, in particular, the role of the negative
domain seen most clearly in Figure 2.9D–F, can be assessed by a comparison of BLG-A and
BLG-B. The type 1 titrations in Figure 2.7 reveal aggregation rates an order of magnitude
higher for the -A isoform. Focusing first on the crossing points where turbidity is
independent of the direction of titration, it is reasonable to suggest that these represent the
rate of aggregation of the dimer (first step). The crossing points of pH 5.2 and 5.4 for AA and
BB, respectively, suggest that an increase in pH to 5.4 for BB results in behavior similar to
that of AA at pH 5.2. Thus titration with NaOH up to pH 5.0 involves more retention of net
positive protein for BLG-B (pI ∼5.2) than for BLG-A (pI ∼5.1), accounting for the
accumulation of fewer aggregates and the absence of a crossing point. Comparison with
Figure 2.1 shows that the aggregation rate at pH 5.0 (high to low titration) for native BLG is
lower than that for AA by a factor of 3, even though the protein concentration is twice as
large for the native form. The finding that the turbidity of native BLG (Figure 2.1) is much
smaller than the sum of the contributions of AA and BB (Figure 2.7) is also in agreement
with earlier observations that BB suppresses the aggregation of AA.
2.5.5 Turbidimetric Titration of BSA
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The charge anisotropy of BSA (Figure 2.10) is distinctly different from that of BLG.
As in the case of BLG, the absence of any influence of the titration direction on the pH of the
maximum aggregation rate (pHmax) reflects the dominant role of the charge anisotropy of the
free protein. However, pHmax is above pI for BSA vs. below pI for BLG. There are two
possible explanations for this effect. If positive patches are stable at low pH, as is the case for
BSA in the range of 4.5 < pH < 6,64 then the aggregation rate will be determined by the
expansion of the diffuse negative domain at higher pH; if a negative patch is stable at high
pH, then aggregation will be enhanced by the expansion of a diffuse positive domain at lower
pH. This scenario describes BSA and BLG, respectively. The second explanation involves
two steps, the first some form of nucleation and the second reflecting the tendency of net
charge to oppose cluster formation. Preliminary kinetics experiments suggest that this twostep mechanism is consistent even at 10-fold-higher protein concentrations. Because the two
steps have different pH and concentration dependences, the transition from step 1 to step 2
during the course of a type 1 titration will depend not only on the direction of titration but
also on the rate of acid/base addition and on the total protein concentration. A more detailed
investigation of this scenario would involve monitoring the initial and aggregated species by
DLS as a function of the direction and rate of pH change, which is beyond the scope of the
current work.
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Figure 2.10: Electrostatic potential contours (+0.5kT/e (blue) and −0.5kT/e (red)) around
BSA at an ionic strength of 0.0045 M and pH 5.4 (conditions identical to those for BLG in
Figure 2.9G).

2.6 Conclusions
Turbidimetric pH titrations (type 1 titration) conveniently provide accurate
measurements of the pH-dependent rate of aggregation (dτ/dt) of native state proteins: the pH
of the maximum aggregation rate (pHmax) and the ionic strength dependence of (dτ/dt) are
equivalent to results from kinetic measurements. The results for BLG lead to the
identification of two predominantly electrostatic steps. The rate of the first step, ascribed to
the aggregation of free protein and dominated by charge anisotropy, is symmetrical around
pHmax (4.9) and inversely proportional to the ionic strength. At pHmax, DLS kinetics shows
the rapid growth of apparent size at early time relative to that at pH 5.1, whereas SLS of
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aggregates at both pHs shows the formation of increasingly dense structures consistent with
particle–cluster aggregation. The relatively slow aggregation rate in the second step varies
linearly with pH at constant I for pH < pI and is inversely proportional to I

0.25

. This process is

due to the association of clusters with inhomogeneous and mobile charge surfaces. The role
of charge anisotropy in the first step is substantiated by the more rapid aggregation of the A
isoform of BLG and by the contrasting aggregation behavior of BSA with inverted charge
anisotropy.
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Figure 2.11: Type 1 titration of 1.0 g/L BLG from high to low pH with titration rates of 0.4
pH unit/min, 0.2 pH unit/min, and 0.13 pH unit/min.

Figure 2.12: 1 g/L BLG in 0.0045 M NaCl was titrated with 0.1 N HCl to pH 4.6 (the point
of maximum turbidity) (lower curve, □). The absence of any time dependence (upper curve,
○) confirms the equality of aggregation and disaggregation rates at this condition.
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Figure 2.13: (A) Type 1 titration of 1.0 g/L BLG with 0.1 N HCl in 0.0045-0.1 M NaCl. (B)
Ionic strength dependence of (-dτ/dpH)max. Insert: (-dτ/dpH)max vs I-1, agreement with kinetic
studies confirms31 extraction of rates from type 1 titration.

Figure 2.14: Mass spectra of BLG-A and BLG-B mixture (wt/wt, 1/1; CBLG = 1.0 g/L) at pH
6.3. MS shows that “native” BLG is a statistical collection of AA, BB and AB with a ratio of
1:2:1.
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Figure 2.15: Type 1 titration of 1.0 g/L BLG in 0.0045 M NaCl with 0.1 N HCl.
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CHAPTER 3
STRUCTURE OF BOVINE β-LACTOGLOBULIN–LACTOFERRIN
COACERVATES
Ebru Kizilay, Daniel Seeman,* Yunfeng Yan, Xiaosong Du, Paul L. Dubin, Laurence
Donato-Capel, Lionel Bovetto, and Christophe Schmitt Soft Matter, 2014, 10, pp 72627268
*

corresponding author

3.1 Abstract
Lactoferrin (LF) and β-lactoglobulin (BLG) are among the protein pairs that exhibit
heteroprotein coacervation, a unique and relatively unexamined type of liquid–liquid phase
separation (LLPS). In prior work we found that LF and BLG undergo coacervation at highly
constrained conditions of pH, ionic strength and protein stoichiometry. The molar
stoichiometry in coacervate and supernatant is LF:BLG2 1:2 (where BLG2 represents the 38
kDa BLG dimer), suggesting that this is the primary unit of the coacervate. The precise
balance of repulsive and attractive forces among these units, thought to stabilize the
coacervate, is achieved only at limited conditions of pH and I. Our purpose here is to define
the process by which such structural units form, and to elucidate the forces among them that
lead to the long-range order found in equilibrium coacervates. We use confocal laser
scanning microscopy (CLSM), small angle neutron scattering (SANS), and rheology to (1)
define the uniformity of interprotein spacing within the coacervate phase, (2) verify structural
unit dimensions and spacing, and (3) rationalize bulk fluid properties in terms of inter-unit
forces. Electrostatic modeling is used in concert with SANS to develop a molecular model
for the primary unit of the coacervate that accounts for bulk viscoelastic properties. Modeling
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suggests that the charge anisotropies of the two proteins stabilize the dipole-like LF(BLG2)2
primary unit, while assembly of these dipoles into higher order equilibrium structures
governs the macroscopic properties of the coacervate.
3.2 Introduction
Complex coacervation, a spontaneous liquid–liquid phase separation, can be
exhibited under a wide range of conditions by a variety of systems including: oppositely
charged polyelectrolytes (PE),65 or PEs in combination with oppositely charged macroions
including proteins66, 67, 68 micelles69, 70 or dendrimers.71 These phenomena all differ from
coacervation of oppositely charged proteins72, 73, 74 which is known to arise from the tendency
of those macroions to assemble as dense, homogeneous fluids under a very limited range of
stoichiometry, ionic strength and pH.72,

75

Heteroprotein coacervation is still a largely

unexplored phenomenon, with the majority of publications originating from a single group,
in many cases not explicitly identified as complex coacervation.76, 77, 78 The lactoferrin–βlactoglobulin system serves as one example of a heteroprotein coacervation with
characteristic dependence on the aforementioned variables.75
The relatively few papers reporting on heteroprotein coacervation reveal substantial
differences from classic examples of complex coacervation. Soluble complexes have been
established as precursors in nearly all typical forms of macroionic coacervation79 and in some
cases, particularly those involving PE–colloid systems, these complexes and aggregates
thereof have been well characterized by techniques such as light scattering80 and
electrophoresis81, 82 and neutron scattering.83 Evidence for analogous primary complexes in
heteroprotein systems is currently very limited. Charge stoichiometry ([+]/[−]) appears to
play a different role for heteroprotein vs. PE–PE or PE–colloid coacervation, often appearing
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in the latter case as the dominant factor determining coacervation yield, but apparently a
necessary but not sufficient condition for heteroprotein coacervation.84 The range of charge
stoichiometry over which this form of coacervation can occur seems more narrower than for
the more typical macroionic systems.85 The difference between highly flexible polyions and
conformationally rigid globular proteins would of course be expected to have dramatic
consequences because of the limitations of ion-pairing on intermolecular mixing in the
protein–protein case, leading to a greatly reduced role for counterion release and
configurational entropy in the heteroprotein system. Phenomenological studies of the
conditions under which heteroprotein systems coacervate have illuminated some of these
issues.86, 87
In our previous study,75 we used turbidimetry and dynamic light scattering (DLS) to
examine the conditions that lead to coacervation in a system composed of two bovine milk
proteins: β-lactoglobulin (BLG) and lactoferrin (LF). Complex coacervation of these two
oppositely charged proteins was obtained only under a very narrow range of ionic strength,
pH, total protein concentration, and protein–protein stoichiometry. The last variable was
constrained to 1:1 weight ratio (1:4 mole ratio). This same stoichiometry was observed in
both supernatant and coacervate, corresponding to complexes that were also detected in less
concentrated one-phase systems. These constraints on conditions for pure coacervation were
attributed to inter alia (1) the requirements for the formation of a basic primary unit,
LF(BLG2)2, and (2) effective competition with BLG self association which depletes free
BLG. However, it is unknown whether this LF(BLG2)2 primary unit is subject to
disproportionation and therefore whether the features of this complex might not be retained
in the resultant structures; and whether the variables such as pH, ionic strength and
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stoichiometry that dictate assembly – within their highly constrained ranges – could affect
the resultant properties of the coacervate.
Here we use confocal laser scanning microscopy (CLSM), small-angle neutron
scattering (SANS) and rheology to better understand the structure of BLG–LF coacervates
formed in the absence of added salt, at pH near 6. Electrostatic and molecular modeling is
used in conjunction with experimental SANS data to determine the geometry and
interparticle spacing of the primary unit of the coacervate LF(BLG2)2. Finally, the apparent
hierarchical structure of the dense phase at different conditions is used to explain the unique
and pH-dependent viscoelastic properties of the coacervate.

3.3 Experimental section
Materials. Bovine β-lactoglobulin (36 kDa) (from Davisco Foods International, Inc., batch
number: JE 001-8-415) and lactoferrin (76–80 kDa) (from DMV International Nutritionals,
Netherlands, batch number: 10444427), supplied by Nestlé Research Center (Lausanne,
Switzerland). The compositions were (g per 100 g wet powder), 97% (for LF); and BLG-A
(55.4%), BLG-B (41.6%), and α-lactalbumin (1.6%) (for BLG). Lactoferrin, an ironcontaining protein has two 2Fe3+ binding sites and appears orange due to iron absorbance.
Milli-Q water was used in all sample preparation.
Preparation of samples for SANS and rheology. Stock 40 g L−1 solutions of each protein
were prepared in filtered D2O for SANS, and in Milli-Q water for rheology. The solutions
were adjusted to a target pH (5.8 or 6.0 for rheology, 6.0 for SANS) using 0.1 N NaOH or
HCl. To prepare coacervates the LF solution was quickly poured into a pre-adjusted BLG
solution in 15 mL centrifuge tubes followed by vortexing for 10 s and centrifuging for 30
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min at 3200 × g. The total starting protein concentration was 40 g L−1 for SANS and
rheology.
Protein labeling. Fluorescently labeled proteins, FITC-BLG and RITC-LF, were prepared
according to Zhang et al.88 Stocks of 5 g L−1 FITC or RITC ethanol solution were added
dropwise under mild stirring into 200 µM BLG or LF in pH 8.0, 0.1 M phosphate buffer with
a molar ratio (dye–protein) of 2.0. After 1 h reaction in the dark, labeling was terminated and
free dye was removed by dialysis (10 kDa MW cutoff) against 10 mM Tris–HCl buffer (pH
7.4, 0.6 M NaCl). The external solution was replaced by Milli-Q water to remove salt; at
least 4 times. Bright yellow FITC-BLG and purple RITC-LF were obtained after freezedrying.
Confocal laser scanning microscopy (CLSM). Samples for microscopy were prepared by
mixing 20 g L−1 protein stock solutions prepared in Milli-Q water at pH 6.0, followed by 1.0
h equilibration. The morphology and protein distribution in BLG–LF (containing 0.5‰
labeled protein) droplets were investigated by confocal scanning laser microscope (Leica
TCS SP, Germany). A 50× objective lens was used for generating confocal images in
transmission mode. Emission spectra of FITC-labeled proteins were taken from 500–530 nm
with excitation wavelength 488 nm. Emission spectra of RITC-labeled proteins were taken
from 590–620 nm with excitation wavelength 543 nm.
SANS measurements. Scattering experiments were carried out on coacervates using the CG2 (General-Purpose SANS (GP-SANS)) instrument at Oak Ridge National Laboratory
(ORNL). SANS spectra I(q) were obtained as dependence of intensities on the scattering
vector q = (4π/λ)sinθ, where λ is the neutron wavelength, and 2θ the scattering angle. The
sample was held at 15 °C in a 1 mm quartz banjo cell. Data from two sample-to-detector
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distances (1 and 14 m) were merged to give an effective q-range of approximately 0.004 to
0.48 Å−1 (using 6 Å neutrons). Raw data were processed using data reduction modules
provided by ORNL and then adjusted to an absolute scale by measuring the scattering of a
provided standard at low-q. Prior to merging, scattering from an empty cell was subtracted
from data corresponding to both detector configurations to account for background
scattering, for high-q and low-q data.
Rheology. Rheology of coacervates was measured with a stress-controlled rheometer (TA
Instruments AR-G2) with cone and plate geometry. The samples were loaded at 25 °C with a
measurement gap of 1 mm. After a 15 min conditioning time, dynamic oscillatory frequency
sweeps were made from 100 to 0.1 rad s−1 with an oscillatory strain amplitude of 5%, which
was determined to be in the linear viscoelastic regime for the ranges of frequency and
temperature investigated.
Electrostatic modeling. DelPhi3 V. 4r1.1 was used to model the electrostatic potential
around the proteins as a function of pH and ionic strength. PDB ID 1BLF (diferric bovine
LF) and 1BEB (BLG dimer) were taken from the RCSB Protein Data Bank
(http://www.rcsb.org). Amino acids charges were generated using the spherical-smearedcharged model proposed by Tanford based on titration curves of BLG61 and LF (Figure 3.7).
Atomic coordinates were used to calculate single-particle form factors as well as Rg, for
individual proteins and protein–protein complexes, using CRYSON 2.7.89

3.4 Results
3.4.1 Confocal microscopy. BLG and LF appear to be uniformly dispersed within
coacervate droplets. Confocal laser scanning microscopy was used to investigate the
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distribution of component proteins in (1) BLG–LF suspensions of 10–50 µm droplets,
obtained by mixing labeled LF and BLG at pH 6.0 and Cp = 20 g L−1 (1:1, w/w), and (2)
corresponding coacervates obtained after 24 h settling. The fluorescent label, present at less
than 0.25% total protein, was found to have no inhibitory effect on coacervation. Figures
3.1C and D indicate that BLG and LF are homogeneously dispersed throughout the droplets
at the 20 µm scale.

Figure 3.1: Confocal images of (A) suspensions of FITC-BLG–LF, (B) BLG–RITC-LF, and
(C) and (D) FITC-BLG–RITC-LF; and (E and F) coacervate of FITC-BLG–RITC-LF after
1.0 h equilibration. Cp = 20 g L−1, rwt = 1.0, pH = 6.0, 0 mM NaCl. Excitation wavelengths
488 nm (A, C and E) and 543 nm (B, D and F). Emissions wavelengths 500–530 nm (A, C
and E) and 590–620 nm (B, D and F).
3.4.2 Small-Angle Neutron Scattering (SANS).
Observed scattering can only be explained by the existence of a primary unit with
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dimensions comparable to LF(BLG2)2. The coacervate homogeneity at large length scales
established by CLSM supports the use of SANS and its attendant length scales for
elucidation of coacervate structure, in order to observe structural features too small to be
optically resolvable. In order to extract basic structural information, a series of standard plots
was constructed as shown in Figures 3.2A,B.

Figure 3.2: SANS of BLG–LF coacervate. (A) Porod exponents for all regions (B) Guinier
plot (Rg = 50.5 ± 1.1 Å). Also reported is the correlation length (40 Å) corresponding to q*.
The existence of a second Guinier region is inferred at lower-q.
Data were subdivided according to observed scaling laws, with data between
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approximately q = 0.008 and 0.035 Å−1 used to estimate radius of gyration of 5 nm, via a
Guinier plot (figure 3.2B). For the first Porod region, scattering scales as I ∝ q−1.4, suggesting
a loosely packed structure intermediate between rod and fractal aggregate. While the first
Porod region more closely resembles a branched cylindrical object, the second Porod region,
corresponding to higher order structures, shows scaling more characteristic of a classical
fractal aggregate, suggesting a mechanism by which primary units may assemble to form
larger structures. Additionally a correlation peak, q*, was observed at q = 0.16 Å−1,
suggesting a correlation length of approximately 4 nm, although the broadness of the peak
indicates considerable polydispersity with respect to position and orientation of protein
monomers within a primary unit.
3.4.3 Rheology

Figure 3.3: Dynamic oscillatory frequency sweeps of coacervate formed at pH 6.0, at 5%
strain (G′: closed and G′′: open symbols).
The frequency-dependent viscoelastic moduli of coacervates prepared from BLG and
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LF solutions prepared at pH 6 are shown in Figure 3.3. Oscillatory strain amplitude was
determined to be in the linear viscoelastic regime over the range of frequencies used.
Samples prepared at different mixing pHs (Figure 3.7) – (note that we did not attempt to
measure the pH of the coacervate itself) all show viscoelastic behavior consistent with a
highly viscous liquid, i.e. the storage (elastic) modulus G′ is always less than the loss
(viscous) modulus G′′.

Figure 3.4: G′ and G′′ for coacervates prepared at four mixing pHs, results are shown at ω =
0.1, 0.63, and 20 (s−1); using data from figures 3.3 and 3.7; (A) G′ and G′′ as a function of
mixing pH; (B) Superposition of high frequency (ω > 25 rad s−1) data; (C) pH dependence of
the shift factors used in B.
For coacervates prepared at pH 6, the frequency dependence of G′′ is constant across
all measured ω values up to 100 rad s−1. In contrast, the dependence of G′ on ω increases
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sharply above ω = 10 rad s−1. G′′ is larger than G′ at all measured frequencies, indicating that
any crossover point must occur at ω > 100 rad s−1. This suggests that the interconnected
structures responsible for the viscoelastic properties have characteristic relaxation times
shorter than 0.01 s. Linear extrapolation in Figure 3.3 of G′ and G′′ up to their cross-over
point gives a typical relaxation time of 0.001 s. The viscous modulus (G′′) at ω = 0.1, 0.63,
and 20 is shown to increase dramatically at pH < 6, particularly at higher frequencies (ω =
20) (Figure 3.4A, open symbols).
High frequency (ω > 25 rad s−1) data were superimposed (Figure 3.4B) using a pH
dependent shift factor A0 (Figure 3.4C). The success of this superposition using only shifts in
ω suggests that the shear modulus G0, as obtained from a Maxwell fit (eqn (3.1) and (3.2)),
should be largely invariant with respect to mixing pH.

G′ = G0(ωτ)2/(1 + (ωτ)2)

(3.1)

G′′ = G0(ωτ)/(1 + (ωτ)2

(3.2)

3.5 Discussion
3.5.1 Atomistic Model of the Primary Unit.
Protein charge anisotropy allows us to construct an atomistic model of the primary
unit. The results from SANS can be interpreted on the basis of a molecular model consistent
with the charge anisotropy and structure of the individual protein monomers using two
assumptions: (1) the charge anisotropy of the individual proteins controls formation of
primary units at incipient coacervation, and (2) the dipolar structure of this complex controls
long-range order in separated coacervate phases. This primary unit, LF(BLG2)2 (Figure 3.5)
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was constructed using the atomic coordinates of LF monomer and BLG dimer. The initial
separation between BLG and LF in such complexes was taken to be no more than 6–7 nm.
Coarse refinement of this structure was facilitated by comparison of calculated form factors
with experimental scattering curves. Since the component proteins are chemically and
structurally monodisperse, the only source of polydispersity is orientational and positional
heterogeneity within the primary unit.

Figure 3.5: Proposed arrangement of BLG2 (left): LF (center): BLG2 (right). BLG–LF
separation is taken to be less than 6 nm. Electrostatic potentials are contoured at −0.5 kT/e
(red) and +0.5 kT/e (blue), potentials displayed are for pH 6.0. The calculated radius of
gyration of this primary unit, Rcalcg = 4.5 nm, was obtained from CRYSON.
The coacervate phase appears homogenous at the length scales of optical microscopy,
but the upturn seen at low-q suggests that primary units must associate to form a structure
greater than approximately 70 nm, not fully resolvable in the given q-range. This requires the
existence of an equilibrium structure of dimensions intermediate to those accessible to
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fluorescence microscopy and SANS, and responsible for the bulk coacervate physical
properties.
Data in the range of q = 0.01 to 0.48 Å−1 were compared directly to single particle
form factors calculated89 for BLG2, and LF, alone, as well as from a molecular model of the
proposed primary structural unit. In order to confirm the role of LF(BLG2)2 as the primary
coacervate structural unit, scattering calculated from this model (Figure 3.6C) was compared
directly to SANS data, as shown in Figure 3.6. The ‘refined’ primary unit (Figure 3.6C) is a
minor structural rearrangement of the atomistic model shown in Figure 3.5.

Figure 3.6: SANS data 0.004 < q < 0.48 Å−1 (open symbols) are presented alongside (A)
calculated form factors for individual protein components LF, Rcalcg = 2.8 nm and BLG2,
Rcalcg = 2.1 nm, as well as for a form factor calculated from their arithmetic sum. (B) Form
factor calculated from the proposed model of the primary unit, LF(BLG2)2 (C) refined
geometry of primary unit, BLG2–LF–BLG2.
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3.5.2 SANS is not Simply Additive
Scattering cannot result solely from free LF or BLG2. It is clear from Figure 3.6A that
scattering calculated from either component protein, or from their weighted sum, is
inadequate to explain results below q = 0.12 Å−1. Diminution of scattering in Porod region #1
(see Figure 3.2) must be due to short-range interactions between the two proteins, while the
upturn at very low q must result from higher-order structure comprised of assemblies of
primary units. The observed exponent 1.4 is consistent with the absence of well-defined
interfaces for these assemblies, in contrast to the scattering curves for individual proteins.
The less well-defined peak at q* in Figure 3.2 derives its breadth from a wider range of
primary unit geometry in the actual sample.

3.5.3 Proposed Structure of LF(BLG2)2
The proposed structure of LF(BLG2)2 has dimensions consistent with those obtained
from experimentally observed scattering. To determine the basis of these deviations in qdependent scattering, a molecular model of the primary unit, described by LF(BLG2)2, was
constructed based on considerations of protein electrostatics. The initial, unrefined, model is
presented in Figure 3.5, while scattering calculated from the refined configuration (Figure
3.6C), is shown above (Figure 3.6B). This arrangement adequately predicts the diminution of
scattering intensity between q = 0.1 and 0.01 Å−1, suggesting that the data could best be
described as an average of the angle-dependent scattering from a large ensemble of primary
unit configurations with subtly different spacing and geometric arrangements. The calculated
radii of gyration for the ‘unrefined’ and ‘refined’ models are in the range of 4.5 to 4.7 nm,
consistent with dimensions obtained by Guinier analysis of figure 3.2.
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3.5.4 Long-Range Order Through Inter-Primary Unit Interactions
Individual form factors for BLG dimers and LF monomers (Figure 3.6A) are
insufficient to explain observed SANS data, but most scattering between q = 0.01 and 0.1
could be ascribed to the primary unit itself LF(BLG2)2, as represented by the average of an
ensemble of different configurations. This leaves only the upturn at low-q unexplained,
presumably resulting from association of primary units. Their organization can be
characterized by a scaling law characteristic of loosely packed particles. One possible
explanation for the observed long range order would be that the same protein charge
anisotropy that stabilizes the LF(BLG2)2 primary unit also leads to attractive electrostatic
interactions among primary units. This results in a network bridged by protein dipoles over a
narrow range of length scales.
Changes in mixing pH should affect the fractional charges of titratable residues in
both proteins, which are expected to affect the interactions among dipoles. The existence of a
common value of G0 for all mixing pH values supports a conserved elastic structure in all
cases, while the decrease in characteristic frequency implies that the dynamics of the system
are dramatically dependent on pH. This suggests that the lifetime of association of primary
units or clusters varies with the crossover frequency, while the overall coacervate structure is
preserved. Rheological properties likely arise from rearrangements of BLG2 and LF within
primary units, which may allow for optimization of repulsion and attraction.
CSLM reveals the presence of spherical and deformed droplets coalescing to form the
coacervate, which can be interpreted as a sign of macroscopic viscoelasticity, consistent with
findings from rheology. Solvent vacuoles within some droplets (Figure 3.1), is a sign of local
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reorganization. This finding suggests that the coacervate can be characterized by motion on
different time- and length-scales, as shown by rheology and SANS respectively. The absence
of vacuole structures in the ALAC–LYS systems studied by Nigen et al. may suggest unique
features of the LF–BLG2 coacervates. The dissimilar tertiary structures and a high degree of
charge asymmetry of BLG2 and LF might facilitate the assembly of the unique structural
unit, LF(BLG2)2.

3.6 Conclusions
Since neutron scattering of BLG–LF coacervates is poorly explained by a single,
spatially fixed BLG2–LF unit there must be ongoing intra-unit reorganization. Rheology
verifies this assumption, showing that the elasticity of a network formed by the primary units
is largely pH independent, while the shift in frequency dependence with pH reflects changes
in the motions of individual proteins.
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3.8 Supporting Information

Figure 3.7: Dynamic oscillatory frequency sweeps at 5% strain (G’: closed and G”: open
symbols) for coacervates prepared at four different mixing pHs. Triangles: pH 6.0, inverted
triangles: pH 5.8, circles: pH 5.9 and squares: pH 6.1.

Figure 3.8: Potentiometric titration of bovine lactoferrin (LF) at room temperature (ca. 25oC)
with no added salt. [LF] = 20.8 g/L, total volume = 10 mL. Charge curve is the result of a
high-to-low titration from isoionic pH using 0.1N HCl, and a low-to-high titration, starting
from the same pH, using 0.1 N NaOH.
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CHAPTER 4
NON-FREEZING WATER STRUCTURATION IN HETEROPROTEIN
COACERVATES
Xiaosong Du, Daniel Seeman*, Paul L. Dubin, and David A. Hoagland 2015, (submitted
May 2015)
*

corresponding author

4.1 Abstract
Surface-bound water in protein solutions has been identified with a reduction in its
freezing point. We studied the presence of such non-freezing water (NFW) in various
protein-polyelectrolyte,

micelle-polyelectrolyte,

and

protein-protein

(heteroprotein)

coacervates, along with appropriate concentrated solutions of macromolecules alone, finding
up to 15% w/w of NFW for the heteroprotein coacervate of lactoferrin (LF) and βlactoglobulin (BLG). The level of NFW is always higher in coacervates than in the control
(single-macromolecule) systems, particularly for protein-containing coacervates: a
coacervate of bovine serum albumin (BSA) and poly(dimethyldiallylammonium chloride)
(PDADMAC) showed a ratio of NFW/protein twice that of BSA alone (0.6 vs. 0.3), with a
similarly high ratio for LF-BLG coacervate. These results are attributed to maximization of
water-protein contacts, structural features that reflect the mode of sample assembly, as they
are not seen in a non-coacervated LF-BLG solution with identical concentrations of all
species.
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4.2 Introduction
There has been long-standing interest in the role of protein hydration in crowded
solutions of macromolecules, because such systems can serve as models for simple biological
ones. At high protein concentration, hydration water has been shown to slow the effective
diffusion of protein monomers relative to that in dilute solutions,90, 91 possibly mediated by
an increase in the protein’s effective hydrodynamic size,92 or simply by protein-water
interactions.93,

94

In order to understand the movement of proteins within such high-

concentration solutions, it is also necessary to consider the diffusion of water molecules
within a highly confined environment, a factor that controls both apparent molecular shape
and size of the protein.95, 96 The confinement of water near a protein surface carries a large
entropic penalty; however, the formation of large numbers of enthalpically favorable
hydrogen bonds, both among water molecules and with the protein surface, can often
compensate energetically, with some theoretical treatments suggesting that such
compensation is an essential feature of protein hydration.97 The entropic portion of proteinsolvent interactions in hydrated systems, is heavily influenced by electrolyte-mediated
ordering of water molecules, similar to that seen in biological systems,96,

98

which, can

enhance repulsive protein-protein interactions, while disordering of water facilitates
attractive interactions96 and loss of solubility. 99
Non-cognate or partially synthetic systems can resemble simple single-celled
organisms:

both

are

capable

of

sequestering

and

compartmentalizing

charged

macromolecules and establishing concentration gradients without the use of fixed
membranes. Similarly, semi-permeable micro-compartments, consisting of conjugated
protein–polymer building blocks, were seen to be capable of guest molecule encapsulation,
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selective permeability and gene-directed protein synthesis.100 The robust and porous microarchitectures in these biomimetic protocells were able to withstand partial dehydration and
rehydration, allowing these protocells to be used in sustained storage and release of drugs
and other bioactive molecules. Many such biomimetic systems can be formed from
coacervates, or coacervate droplets, including those made from biological precursors.
Coacervation in E. coli cell lysate-containing macromolecular components was found to
create artificial, cell-like compartments in which the rate of mRNA production increased
significantly with a transcription rate strikingly similar to those in vivo.101 Coacervate
droplets composed of polyelectrolyte and mononucleotides were used as a biomimetic
reaction medium to stabilize the catalytic activity of contained enzymes.102 A more recent
review article by Keating103 suggests that complex coacervation might be responsible for the
segregation of nucleic acids in early protocells.
Complex coacervation is a special form of macromolecular liquid-liquid phase
separation (LLPS) that gives rise to unique dense fluids with unusual sub-micron
heterogeneity. In contrast to LLPS seen in many colloidal systems, complex coacervation
arises from complexes of oppositely charged macroions formed by non-specific electrostatic
interactions.20 In typical LLPS systems, the homogeneous dense phase differs from the dilute
phase only with respect to concentration; this is described by a coexistence plot, which
expresses composition as a function of solute-solute interaction or temperature. In complex
coacervation, however, the dense phase is not simply a more concentrated version of the
dilute phase but exhibits microsopic heterogeneity due to the reorganization of the complex
precursors; such ordering can be observed through structural or dynamic measurements.104
Coacervation is also distinct from aggregation, not being subject to kinetics, and thus

!

62!

displaying neither the corresponding fractal dimensions nor any internal interfaces.70 A third
notable feature of coacervates is the coexistence of dense and dilute microdomains within the
equilibrium dense phase.79 If these dense microdomains are essentially free of water, then
most of the water in the coacervate should be bulk, i.e. normal freezing water (FW), and the
amount of this FW should resemble the total amount of water. In contrast, concentrated
protein solutions are known to exhibit varying amounts of “non-freezing” water,105, 106, 107
related to protein solvation.108, 109, 110, 111 Thus, if proteins in the dense domains of proteinbased coacervates are well solvated (with or without rapid dynamics), much of the water
should be NFW. Hence, comparison of NFW content should provide insight into the exact
nature of dense microdomains within protein complex coacervates.
The formation of heteroprotein coacervates (HPCs), the most recently investigated
category of complex coacervation72,

87, 112

provides evidence of considerable structure

formation. These HPCs differ from simple concentrated protein solutions in that they have (1)
well-defined structure at the protein level87, 113 and (2) substantial amounts of long–range
order.112, 113 This structuration is expected to involve overlap of protein hydration shells,
resulting in large amounts of confined water. The formation of HPC from β-lactoglobulin
(BLG) and lactoferrin (LF), to our knowledge the most studied HPC, is accompanied by
expulsion of protons114 due to a pK shift and involves a preferred orientation of the primary
structural unit and assembly thereof113 while an uncoacervated concentrated protein solution
does not. This expulsion of protons was found to enhance protein dipoles and orientation of
primary units within the coacervate, to a greater degree than that found in the uncoacervated
BLG-LF mixture.113, 114 In HPCs, the separation of primary units may not be uniform over
longer length scales,72,
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but rather include local regions of lower water concentration
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corresponding to locally organized primary unit “dipoles”.113 Thus, water trapped within
HPCs should be more “perturbed” than the average water in a randomly organized simple
binary protein mixture.
HPC structuration should differ from that found in more conventional coacervates,
e.g. PE-PE, PE-micelle, and PE-protein systems. While average interprotein separation
within HPCs and protein-PE coacervates might be similar, the heterogeneity and dynamics of
protein sub-assemblies must differ in the presence of a protein-binding PE whose organizing
effect can be seen by Cryo-TEM115 and DLS,116 indicating protein-rich and protein-poor on
length scales on the order of more than 100 nm. Total internal fluorescence microscopy of
BSA-PDADMAC coacervates117 shows 200-400 nm protein-rich regions with lifetimes >
100 ms, indicating highly desolvated, even solid-like, domains from which water is likely to
have been expelled along with counterions. HPCs are thus expected to have more uniformly
distributed water than e.g. protein-polyelectrolyte coacervates. Water is thus more uniformly
distributed in HPCs than in protein-PE coacervates, but measurements of NFW in
coacervates have not been reported.
The purpose of this study is to gain insight into the properties of water confined
within the coacervate phase, reflecting the intimacy of contacts between water and the
macromolecular components. Here we examine water structure in HPCs in terms of nonfreezing water. Calorimetric methods such as differential scanning calorimetry (DSC) have
been used to monitor phase changes of water in polymers.118 Such thermodynamic
measurements permit the characterization of hydrated systems without recourse to detailed
molecular models. We consider three coacervating systems with distinctly different
components: protein-PE coacervates comprised of BSA and PDADMAC,104 PE-micelle
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coacervates formed from PDADMAC and SDS/TX-100 mixed micelles,119 and a HPC of
BLG and LF.113 In addition, we carry out a unique and important comparison: we examine
this HPC vis-à-vis a concentrated but not coacervated one-phase mixture of LF and BLG
identical to the coacervate with respect to concentrations of all species, including water, the
two macroions, NaCl, and [H+].

4.3 Experimental Section
Materials. The PDADMAC sample (gift from W. Jaeger, Fraunhofer, Golm) was prepared
by free radical aqueous polymerization of diallydimethylammonium chloride and
characterized after dialysis and lyophilization by membrane osmometry (Mn = 141 kDa) and
light scattering (Mw = 219 kDa). BSA (68 kDa) with total free acid content ≤ 1.2 mg/g was
from Roche Diagnostics (Indianapolis, IN; CAS 9048-46-8). BLG (monomer MW 18 kDa)
and LF (76-80 kDa) were gifts from C. Schmitt (Nestle, Lausanne). Triton X-100 (TX-100)
was purchased from Aldrich, sodium dodecyl sulfate (SDS, purity > 99%) from Fluka. NaCl,
sodium acetate, sodium phosphate (monobasic), and standard NaOH, HCl, and acetic acid
solutions were from Fisher Scientific. Milli-Q water was used in all sample preparation.
Aluminum DSC pans and lids were purchased from TA Instruments, Tzero® technology.
Turbidimetric Titrations. Highly precise turbidimetric titrations (%T ± 0.05%) were carried
out for solutions containing proteins, micelles and polyelectrolytes in order to determine the
points of complex formation and phase separation (pHc, pHf). Within the range of 23-25 °C
no temperature effect could be seen.
Preparation of Coacervates. To prepare PE-micelle coacervate, 4 g/L PDADMAC, in 20
mM TX100 I = 400 mM (NaCl), was titrated with 60 mM SDS (I = 400 mM NaCl) using a
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2.0 mL Gilmont microburet to bring the solution to mole fraction SDS, Y =0.4. In order to
form the PE-protein coacervate, BSA and PDADMAC were mixed together first in pH 5.0, I
= 100 mM (NaCl) Milli-Q water to yield a solution 30 g/L in BSA and 6 g/L in PDADMAC.
pH was then adjusted to 8.0 by the addition of 0.1 N NaOH. All three systems were brought
to their respective coacervation states by adjustment of SDS content for the PE-micelle
system, or pH for the protein-containing systems (see Figure 4.1). For protein-protein
coacervate, LF and BLG were mixed to yield a solution of 20 g/L LF and 20 g/L BLG in pH
6.0 (no salt) followed by vortexing for 10 s. For each of the three systems, the resulting
turbid suspensions of coacervate droplets were centrifuged (Beckman Coulter Allegra 6R)
for 1 h at 4000 rpm, 20 °C to produce optically clear dilute (upper) and dense (lower) phases
(supernatant and coacervate, respectively). The water content in coacervate (WH2O),
determined by comparing coacervate samples prior to and after freeze-drying, was 80%, 84%
and 86% for LF/BLG, BSA/PDADMAC and Micelle/PDADMAC, respectively.
Differential Scanning Calorimetry (DSC) of Coacervates. Coacervate samples, 6-10 mg,
were placed in hermetically sealable aluminum pans. Tests were run using a TA Instruments
Q100 DSC equipped with an RCS cooling system in nitrogen, with a N2 flow rate of 50
mL/min. Phase transitions of water were investigated by cooling the sample to −30 °C,
equilibrating for 10 min and then heating to 30 °C at a rate of 5 °C/min, a heating rate that
providing a good calorimetric response a to the physical phenomena occurring during the
scan. On the basis of better instrument performance in heating mode, DSC analysis was
performed only by imposing single heating ramps. Area of peaks and onset temperatures of
melting were obtained automatically using Universal Analysis software from TA Instruments.
The calibration of the instrument with pure water yielded the melting enthalpy of bulk water
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(DHw) as 323 J/g. The weight of freezable water (Wf) and non-freezing water (Wnf) were
determined from integration of the endothermic peaks. Wf in coacervates can be determined
as:
Wf = DHc/DHw×100%

(4.2)

where DHc is the melting enthalpy of water in the solution. Wf is used to determine Wnf:

Wnf = 1-DHc/DHw×100%

(4.3)

In eqns (4.3) and (4.4) all the weight quantities denoting the different water states are relative
to the total weight of water content.

4.4 Results & Discussion
Turbidimetric titrations were performed by addition of SDS to mixtures of PDADMAC
and SDS/TX-100 mixed micelles, or NaOH to solutions of PDADMAC/BSA and BLG-LF,
to determine regions in which LLPS occurs, leading to the formation of a second phase,
indentified as the coacervate phase. The results are shown in Figure 4.1. Coacervation
involving PEs requires inter alia charge neutralization of soluble complexes,104 i.e.

ZT = 0 = ZPE + nZC

(4.4)

where ZT is the total charge of the polymer chain with bound oppositely charged colloids,
ZPE is the charge of polyelectrolyte, ZC is the charge of the colloid, either protein or micelle,
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and n is the number of colloids bound per polymer chain, which depends on the affinity of
the colloid for the PE, as represented by its binding constant. On the other hand, HPCs
require a very precise balance of repulsive and attractive interactions in order for
coacervation to occur, shown to be between pH 5.7-6.2 for BLG-LF HPCs.113

Figure 4.1: Turbidimetric titrations of (A) PDADMAC/micelle, (B) PDADMAC/BSA and
(C) BLG-LF solutions. The onset of coacervation corresponds to the slope change, i.e. Y =
0.3 (A), pH = 7.3 (B) and pH = 5.2 (C).
4.4.1 DSC is Used to Extract NFW Content
Data obtained from heating scans for different coacervate samples (Figure 4.1) are
summarized in Table 4.1. From the calorimetric traces (Figure 4.2) it can be observed that the
endothermic melting peak is present for all coacervate samples. It is worth noting that
coacervate samples display a DSC trace characterized by a single melting peak. This
phenomenon can be attributed to the existence of only one type of freezable water. Each
coacervating systems shows a different onset temperature of water melting (To), which is
defined as the point of departure from the line of zero slope. PE-micelle coacervates gave the
lowest To followed by PE-protein and HPC systems. The amount of non-freezable water is
defined as the water amount present in the coacervate not associated with the endothermic
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peak. It seems that PE-containing coacervates have similar Wt, Wf and Wnf regardless of the
colloid. However, HPCs have lower Wf and higher Wnf than the PE-containing coacervates.

Figure 4.2: DSC scans of (A) PDADMAC/micelle, (B) PDADMAC/BSA and (C) BLG-LF
samples.
4.4.2 NFW in Coacervates vs. Uncoacervated Mixtures
All coacervates were shown to have lower Wf and higher Wnf than uncoacervated
mixtures of concentrated macroions prepared at concentrations equivalent to those in the
coacervate. While the level of NFW is always higher in coacervates than in such
concentrated one-phase samples, the difference is particularly notable for HPCs, which show
a 5-10 fold increase in NFW.
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Table 4.1: Freezable water (Wf), non-freezing water (Wnf) content for different systems.
Wmolecules a
(g)

DH
(J/g)

Wf
(wt%)

Wnf b
(wt%)

Wnf/Wmoleculesc

250

313±4

97±1%

3±1%

0.12±0.04

250

273±7

85±2%

15±2%

0.6±0.1

LF

125

323±2

100%

0

0

BLG

125

322±2

100%

0

0

163

305±3

99±1%

1±1%

0.1±0.1

163

276±6

90±2%

10±2%

0.6±0.1

BSA

130

293±3

95±1%

4±1%

0.3±0.1

PDAD

33

305±4

99±1%

1±1%

0.3±0.3

190

286±4

96±1%

4±1%

0.2±0.1

190

273±6

92±2%

9±2%

0.5±0.1

Micelle

153

286±4

96±1%

4±1%

0.3±0.1

PDAD

37

292±3

98±1%

2±1%

0.5±0.3

Concentrated
LF/BLG
LF/BLG
(coacervate)

Concentrated
BSA/PDAD
BSA/PDAD
(coacervate)

Concentrated
Micelle/PDAD
Micelle/PDAD
(coacervate)

a

The weight of macromolecules per 1000 g DI water. b Percentage of non-freezing water
relative to total water % NFW/(NFW+FW). c Weight ratio of non-freezable water (NFW) to
macromolecules.
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A

B

C

D

Figure 4.3: Representation of networks of hydration water in uncoacervated (A,C) and
coacervated (B,D) protein solutions; visualized in a 50 nm × 50 nm plane with a thickness of
5 nm; assumes ca. 1.5 nm of hydrated water per protein. (A) 125 g/L LF + 125 g/L BLG2,
(B) 250 g/L LF(BLG2)2. (C) 130 g/L BSA, and (D) 37 g/L PDADMAC/ 130 g/L BSA
4.4.3 Role of Protein Hydration
The remarkable amount of NFW seen in the protein systems suggests that protein
hydration is strongly affected by the coacervation process. This is most significant for BLGLF coacervates, which have the largest value of NFW, and stands in contrast to the negligible
amount of NFW for the free proteins.

A similar, but smaller, effect is seen for the

BSA/PDADMAC coacervate. It appears likely in both cases that, perhaps counter-intuitively,
the number of protein-water contacts (i.e., level of hydration-water) is increased in the
coacervates, relative to a control, which comprises the sum of concentrated BLG and LF
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solutions. This could happen if protein-protein contacts are, in fact, diminished (i.e., replaced
by protein-water contacts) in the coacervate. Figure 4.3 portrays this type of “structuration”
in which electrostatic interactions between LF and BLG, on the length scale corresponding to
average separations of ca. 1-2 nm between LF and BLG,113 lead to an organization that in
fact reduces intimate protein-protein contacts, thus enhancing protein-water contacts.

4.4.4 Structuration during the Coacervation Process
BLG-LF HPCs differ from simple concentrated protein solutions in multiple regards.
Such factors include (1) the narrow range of preparation conditions (e.g., pH and I) that result
in coacervation and (2) the existence of a well-defined structural unit, with a fixed
stoichiometry. The large hydrodynamic volume occupied by the highly-hydrated
coacervating species LF(BLG2)2 with Rg ca. 4-5 nm,113 maximizes the number of proteinwater contacts, compared with protein-alone solutions. Such concentrated proteins in
uncoacervated samples, should have a large number of, unstructured, protein-protein
interactions (e.g., aggregates or multimers), limiting the amount of possible protein-water
interactions). Thus there is a significant structuration of water, relative to concentrated
protein solution, when BLG2 and LF are consolidated into a single primary unit, of limited
flexibility that forms a structural unit of Rh ca. 4-5 nm, large enough to retain protein
solvation shells.
For the BSA-PDADMAC coacervate, which exhibits the next largest NFW effect,
inhibition of protein-protein contacts occurs by a different process, as shown in Figure 3D:
protein-protein interactions are replaced by protein-polyelectrolyte interactions. A substantial
body of literature demonstrates the reduction of rates of protein aggregation in the presence
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of binding polyelectrolytes.120, 121 This is also consistent with the notable observation that
PDADMAC-BSA solutions with 200 g/L protein show no changes in DLS spectra even after
extended storage at room temperature.122
Systems in which BSA is replaced with SDS/TX-100 micelles show NFW patterns
that resemble those of the protein systems, but comparisons are greatly complicated by the
very high ionic strengths required for formation of SDS/TX100/PDADMAC instead of
precipitates. For this reason, and because of the very limited understanding of water structure
in concentrated ionic micelle solutions, we hesitate to make comparisons with the protein
systems.

4.5 Conclusions
An enhancement of nonfreezing water content was seen in several coacervating
systems: LF/BLG (heteroprotein) coacervate; PDADMAC/BSA (PE-protein) coacervate; and
a coacervate formed between PDADMAC and the anionic/nonionic (SDS/TX-100) mixed
micelle. All coacervates were found to contain high levels of NFW, ca. 9-15% of total water.
Comparisons to uncoacervated controls confirm that the coacervation process is responsible
for maximizing protein-water contacts, i.e. NFW, in protein-containing coacervates.
Compared to both PDADMAC/BSA and PDADMAC/micelle coacervates, heteroprotein
coacervates have a higher percentage of NFW and a larger ratio of NFW to total
macromolecule concentration. This can be attributed to a well-defined structural unit
LF(BLG2)2 whose expanded configuration enhances protein-water contacts at the expense of
protein-contacts. Similar compensating effects are responsible for a slightly lower NFW level
of PDADMAC/BSA coacervates.

!

73!

4.6 Acknowledgements
This project was supported by the National Science Foundation (CBET-1133289,
CBET-0966923), and MRSEC in UMass-Amherst. We thank Prof. Ilja Voets for helpful
discussions.

!

74!

CHAPTER 5
PROTEIN CHARGE ANISOTROPY AND PHASE SEPARATION ROLE OF
ELECTROSTATICS IN SELF-ASSOCIATON OF MONOCLONAL ANTIBODIES

Daniel Seeman, Paul L. Dubin 2015, (In Prep)

5.1 Abstract
Turbidimetric self-association rates of mAb (%T min-1) at low temperature, T = 11oC
show a maximum in disaggregation at pH < 7.5, when pH is adjusted from high-to-low.
Titration with 4 M NaCl, at pH 4.5, results in a continuous increase in turbidity, leading to
the appearance of so-called “opalescence”. Antibodies centrifuged at T < 0oC, at pHs 4.5 and
5.9 (Cp = 20 mg/mL) all underwent LLPS. The dense-phase was clearly identified, and a
sharp interface between protein-rich and protein-poor phases was confirmed. Labeled
“contaminant” protein (FITC-BLG) was found to be enriched in the dense phase, suggesting
direct attractive interactions between BLG and mAb-1, which could be disrupted by
changing pH prior to inducing LLPS of mAb.

5.2 Introduction
Liquid-liquid phase separation (LLPS) of monoclonal antibodies (mAbs), driven by
the tendency of these proteins to self-associate under native conditions, can be exploited to
separate mAbs from crude mixtures. The ability to design and produce novel protein-based
pharmaceuticals such as mAbs has surpassed efforts to develop cost effective methods to
purify and formulate.123 Changes in pH and buffer composition124 during purification have
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been shown to produce a wide range of physical transitions, including liquid-liquid LLPS,125,
126

solid-particle formation,127, 128 crystallization,128, 129 and finally precipitation.125, 130, 131
The phase separation temperature of such mAbs is strongly dependent on pH, and I.

The predominant feature of mAb LLPS is the separation of a concentrated, single-component
protein solution into two separate, well-defined aqueous layers without the use of solution
additives. This transition is characterized by a well-defined upper critical solution
temperature (UCST),125,

132

below which self-association leads to separation into mAb-

enriched and mAb-depleted aqueous phases. This depends strongly on pH,125 with clear
maxima at pH conditions that correspond to self-association.133 Literature can be divided into
two primary categories (1) those in which simple additives (salts and nonionic polymers) are
used125, 132 and (2) screens in which complex precipitants and solution additives are used.128
While the latter are more common, it appears that the most important variables in these
screens are ionic strength I, and starting protein concentration (Cp). Similar results can be
obtained simply by varying pH, I and Cp.125, 126
Protein LLPS is an electrostatically controlled phenomena; strong dependence on pH
and I points to an electrostatic cause of self-association. Increases in aggregation number,134
and solution viscosity 133 in mAb formulations have been attributed to electrostatic attraction,
regardless of the protein net charge. The protein charge patch,12 vis-à-vis protein charge
anisotropy,12, 135, 136 has recently been attributed to the strong protein/protein interactions
observed in high concentration solutions of mAbs.137
Non-cognate protein/protein interactions can be controlled via solution pH and ionic
strength. Although much work has been done to minimize phase separation, recent work
suggests that it should actually be possible to exploit this self-interaction to isolate mAb from
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mixtures of host cell proteins (HCPs) and nucleic acids. LLPS of mAbs125, 126, 132 can be
induced at a wide range of pHs and ionic strengths, if T < 0oC incubations are used. This
means that if solution conditions (pH, I) can be found where HCPs do not interact with the
mAb of interest, it should be possible to selectively enrich one phase with mAb. Several
cycles of LLPS could be used to vastly reduce the HCP:mAb ratio in the dense phase.
The goal of this work is to develop LLPS-based methods for purification of complex
mixtures of mAbs (monomer, aggregate, and fragments), HCPs and host cell DNA, as well as
other components of the culture media. Advantages of LLPS for purification would include
(1) simplicity, (2) absence of expensive additives that need to be quantified, and (3) high
levels of electrostatic selectivity. Turbidimetric pH-titrations, coupled with light-scattering
and chromatographic analysis, will be used to identify conditions (pH, I, and Cp) of incipient
phase separation at ambient T. Identifying conditions where interactions result in the
formation of soluble clusters, should be predictive of phase separation at low T. Ultimately,
enhancing mAb self-interaction and minimizing mAb/HCP interactions, should allow for
optimal separation without the need for high MW additives that would require additional
purification steps.

5.3 Experimental Section
Materials. A high isoelectric point therapeutic monoclonal antibody (mAb-1) was obtained
from MassBiologics (Mattapan, MA). The mAb-1 lot used for this study was produced in
CHO cells and purified over a protein A column. mAb-1 has a molecular weight of ca. 150
kDa and a pI of approximately 9.6, as determined by isoelectric focusing. Fluorescently
labeled bovine β-lactoglobulin (BLG) (36 kDa) (Davisco Foods, Inc., batch number: JE 001-
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8-415), was prepared by covalent labeling with FITC, as previously described.88 Orange OT
[1-(o-tolylazo)-2-naphthol] was purchased from Sigma-Aldrich, and Coomassie G-250
(Bradford dye) was obtained from Thermo Scientific; both were used without further
purification.
Turbidimetric Methods. Turbidimetric autotitrations were performed by the addition of
dilute (≤ 0.1N) titrant, NaOH (low-to-high) or HCl (high-to-low) to a solution of mAb-1,
under constant stirring; all experimental variables (pH, transmittance, and time) were
monitored simultaneously; ambient temperature was fixed at 11 °C. Transmittance was
measured using a Brinkmann PC 800 colorimeter equipped with a 420 nm filter and a 1 cm
path length fiber optic probe. Since the rate of pH change (dpH/dt) is known, the
instantaneous rate of aggregation at any pH ((dτ/dt)pH) can be obtained from the product of
(dτ/dpH) and (dpH/dt).
Inducing mAb LLPS. LLPS experiments were conducted by adjusting mAb-1 to a target
pH, at room temperature, prior to lowering to T < 0oC, after which the samples were
centrifuged allowing for gradual temperature increase. This is done at a two different mAb
concentrations (50 mg/mL and 20 mg/mL) and three ionic strengths (I = 10 mM, 140 mM,
and 270 mM). The interface can than be visualized upon addition of a small molecule dye,
Orange OT, which is unable to diffuse into the (highly viscous) lower phase. The protein rich
phase, for mAb alone experiments, is identified by the use of a protein-binding dye (Bradford
Reagent) which changes color proportional to the amount of protein present.
Localization of Contaminant Proteins. Mixtures spiked with low concentrations of dyelabeled “contaminant” proteins with isoelectric points (pIs) and sizes comparable to HCPs
are used to identify non-interacting conditions. FITC-tagged β-lactoglobulin (BLG), a model
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“contaminant” protein with an isoelectric point (pI) around 5.2, is mixed and unlabeled mAb1. The dyed “contaminant” located by visual inspection of the dense phase, post-LLPS. BLG
would be an example of a strongly interacting contaminant protein. FITC-labeled BSA (pI ~
4.9), should be representative of the low pI proteins typically encountered in mixtures of
HCPs from the CHO K1 cell line.138
Computational Methods. DelPhi V. 4r1.1 was used to visualize electrostatic potentials
around mAb-1, as a function of pH and I. A homology model of mAb-1 was constructed
from sequence, using a typical IgG backbone as a template. Amino acid charges were
calculated using a modified form of the spherical-smeared-charge model proposed by
Charles Tanford.4

5.4 Results & Discussion
5.4.1 Self-Association Rates from Turbidity Titrations
Apparent self-association rates (%T min-1) were extracted from a pH autotitration
(Figure 5.1A) performed at a fixed rate of pH change, d(pH)/dt, showing a maximum in
disaggregation, noted by the negative change in turbidity with time, at pH < 7.5 (from high
pH), demonstrating the inherent reversibility of this process, which suggests an equilibrium
system. Titration from low pH, starting at pH = 4.5, show that the rate of turbidity change,
dτ/dt, reported in units of %T/min, is nearly constant, ca. 0.6 %T/min, until around pH 7,
after which it drops sharply until pH 9, where it transitions to disaggregation. This indicates
that mAb self-associates strongly as pH is increased; which must be due to attractive
interactions; while at high pH (still pH < pI) repulsive interactions between mAbs are
sufficient to disrupt aggregates formed at lower pH, maybe due to accumulation of charge on
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such aggregates. However, once the direction of pH change is reversed, the turbidity change,
dτ/dt, increases to a rate nearly identical to that seen at low-pH in the low-to-high direction,
ca. 0.6 %T/min. The rate crosses zero at a pH of 7.5, indicating a hysteresis with respect to
titration

direction,

resulting

from

inequivalent

mechanisms

of

aggregation

and

disaggregation. The rate of disaggregation remains constant, although, remarkably once
d(pH)/dt = 0 at pH 4.5, the solution remains stably turbid, remaining at a τ of approximately
15% T.

5.4.2 Salt Titrations
Subsequent titration of mAb-1 with 4 M NaCl (Figure 5.1B), after having been
adjusted from high-to-low pH at T = 11oC, shows a steady increase in turbidity, hinting at the
existence of soluble precursors, which may ultimately lead to LLPS upon lowering of T. The
rate of turbidity increase, dτ/d([NaCl]) is approximately 1/20 mM-1, up until a total I of
100mM NaCl is reached. Above this ionic strength, the magnitude of dτ/d([NaCl]) drops to
ca. 1/40 mM-1. At this point the solution appears visually turbid in a manner consistent with
literature reports of so-called “opalescence” in antibody solutions, and displays a complete
lack of kinetics, even without continued stirring.
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A

B

Figure 5.1: (A) self-association rates extracted from turbidimetric autotitrations at low T (B)
titration of the same sample with 4 M NaCl leads to “opalescence”, suggesting a precursor to
LLPS.
5.4.3 LLPS after Centrifugation at Sub-Freezing Temperature
A 50 mg/mL solution of mAb-1 was adjusted to pH 4.5 in the absence of added salt,
followed by addition of 4 M NaCl to a final I of 270 mM. The sample was cooled to T < 0oC,
then centrifuged at room temperature allowing gradual warming while spinning (Figure 5.2).
Orange OT was added to the upper phase in order to visualize the sharp interface between the
high- and low- viscosity regions (Figure 5.2A). To verify that the bottom phase was proteinrich, 3uL of the lower (right) and upper (left) phases was isolated, and diluted in an equal
volume of Bradford dye (Figure 5.2B). When transmitted light is blue shifted, it indicates the
presence of protein, when it is red-shifted it indicates its absence. Neither phase is totally
devoid of protein, but the shift towards purple for the upper phase versus a solid blue for the
lower phase, demonstrates that the concentration of mAb in the lower phase is dramatically
enriched relative to the upper phase.
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Figure 5.2: 50 mg/mL solution of mAb-1, 270 mM NaCl after LLPS. Orange OT added
post-centrifugation. (inset) 3 uL of lower- (left) and upper- (right) phases, added to Bradford
Dye. Lower phase is enriched with mAb-1.
5.4.4 Heteroprotein Interactions Persist During LLPS
Sample(s) prepared at pHs 4.5 and 5.9 with 20mg/mL mAb-1 were brought to I = 270
mM via addition of 4M NaCl (Figure 5.3). After LLPS, the samples containing only mAb-1
(not shown) form two discrete aqueous phases, as in figure 5.2A indicating that lower initial
Cp does not inhibit LLPS. Identical samples, spiked with fluorescently-labeled “contaminant”
protein (FITC-BLG), show nearly all dye-tagged protein (yellow) in the lower, mAb-rich,
phase (Figure 5.3). This suggests that direct interactions between FITC-BLG and mAb-1 lead
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to colocalization of the two proteins in the dense phase. Therefore, understanding chargepatch mediated protein-protein attraction will be useful in predicting overall separation
efficiency.

Figure 5.3: LLPS after incubation at T < 0oC. pHs 4.5 and 5.9 [mAb-1]final = 20 mg/mL, I =
270 mM spiked with FITC-β-lactoglobulin.
Quantitative electrostatic modeling of mAbs is used to visualize charge anisotropy as
a function of pH and I (Figure 5.4). Electrostatics is relevant to both (1) self-association
leading to LLPS and (2) mAb/HCP interactions leading to either retention or exclusion of
“contaminants”. Even at pH < pI substantial variation in protein charge anisotropy, or
“patchy-ness”, is observed as a function of pH. This observation suggests that strong
electrostatic attraction, between mAb monomers is still possible at pH << pI.
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Figure 5.4: (A) Electrostatic potentials of mAb-1 at pH 5, 7, and 9, at I = 0.025 mM. ± 0.5
kT/e (B) computed charge curve.
5.5 Conclusions
Phase separation occurs readily at T << UCST for Cp ~ 20 mg/mL. These are low
relative to current literature on LLPS, and show that LLPS is not impeded by low Cp
“contaminants”. pHs where electrostatic attraction between mAb and such model
contaminant(s) is minimized, can be used to reduce the amount of non-mAb protein in the
dense phase. Since both phases are water rich, the dense phase could be easily harvested for
subsequent rounds of LLPS. Since the behavior of mAb monomer is driving phase
separation, it will be possible control the depletion or enrichment of model proteins, or more
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generally HCPs, by controlling the attractions between mAb and HCPs. Direct knowledge of
mAb electrostatics, will be useful in predicting conditions that lead to self-association. It is
conceivable that such work could eventually allow for the design of future mAbs optimized
for purification efficiency as well as formulation stability. This suggests that solution
conditions (pH and I) could be established where LLPS provides separation of crude
mixtures into a mAb-rich and HCP-poor dense phase.

5.6 Acknowledgements
This research was supported by the National Center for Advancing Translational
Sciences, National Institutes of Health, through Grant UL1TR000161. The content is solely
the responsibility of the authors and does not necessarily represent the official views of the
NIH.

!

85!

CHAPTER 6

COACERVATION OF MONOCLONAL ANTIBODY WITH HYALURONIC ACID:
METHODS FOR ASSESSING COACERVATE YIELD AND SELECTIVITY
Daniel Seeman*, Alexander J. Malanowski, Rachel Wollacott, and Paul L. Dubin 2015,
(To be Submitted)
*

corresponding author

6.1 Abstract
A method was developed in order to determine the yield and selectivity of
coacervates prepared from monoclonal antibody (mAb) and hyaluronic acid (HA). The yield
of mAb, in such coacervates, is shown to be as high as 80%, with final concentrations of
mAb-A > 170 mg/mL. Size-exclusion chromatography with multi-angle laser light scattering
detection (SEC-MALLS) shows that, at r = 10 (i.e., a 10X excess of mAb:HA), the yield of
HA is ca. 75%. Removal of HA by ultrafiltration should be easily accomplished. All but one
sample, show complete separation of bovine serum albumin (BSA) from mAb, with the two
proteins going into the supernatant, and coacervate phase, respectively.

6.2 Introduction
Monoclonal antibodies (mAbs) are currently of major pharmaceutical importance, but
their industrial-scale purification involves a complex array of separation techniques,
predominantly expensive and time-consuming chromatographies. This has led to a search for
effective non-chromatographic separations whose selectivity has been demonstrated largely
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by trial and error. Unlike other forms of liquid-liquid phase separation (LLPS), PE-induced
complex coacervation attains high yields and selectivity, based on well-understood effects of
solution conditions, and protein and polyelectrolyte properties. The particular benefits of this
approach have been recently established with the biocompatible natural polysaccharide
hyaluronic acid (HA). Effective analytical methodologies are required to assess the yield and
selectivity of this approach for purification of mAbs, particularly conducive to the analysis of
coacervates formed with HA. High molecular weight HA was selected as a coacervating
agent based on recent success in separating two proteins of similar pI.139
Although monoclonal antibodies have emerged as one of the most prevalent
biotherapeutics,131, 140 representing a large investment in the production of biologics, the
principal challenge arises from purification, typically involving an array of separation
techniques.141 A typical mAb purification consists of cell clarification, affinity
chromatography capture,142, 143 and multiple ion-exchange chromatography steps.144, 145 Cell
clarification based on either centrifugation or microfiltration involves the removal of intact
cells, cellular debris, and other generally insoluble components of the culture media, while
protein A affinity chromatography,146 by far the most effective but expensive part of the
process, is used to selectively capture and concentrate mAbs. Overall production challenges
stem from the large number of coupled and labor-intensive chromatographic steps.131, 141
Thus the development of effective non-chromatographic purification methods has been an
ongoing objective.
Coacervation is known to be a nondestructive and concentrating technique for
inducing phase-separation (LLPS) of target proteins, and thus shows great promise for use in
purification of mAb. Coacervates form when complexes of oppositely charged
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macromolecules, in this case protein and polyelectrolytes (PE), form a new dense phase
enriched in protein. Coacervates formed from complexes of PEs and proteins remain
aggregate-free, and have been shown on numerous occasions to preserve enzyme activity.
Such coacervating systems have been used to deliver proteins such as growth factors,147
vaccines,148 and plasmids;149 or as templates for scaffolds.150, 151 Until recently, the failure to
recognize the remarkable potential for selectivity in PE-protein coacervation has been an
obstacle to applying this uniquely powerful separation process to mAbs.
PE-protein coacervates are reversible equilibrium fluids, in which proteins at high
concentrations remain aggregation-free, and retain structural integrity and activity.
Regardless of starting concentrations, PE-protein coacervates are dense, optically clear fluids
typically containing ca. 200 mg/mL protein, 30-50 mg/mL PE, and 70-80 % water at the
initial ionic strength (I).20 There is no evidence of any time dependence, and enzymes
encapsulated in coacervate droplets have been demonstrated to retain enzymatic activity.152,
153

Low-speed centrifugation easily separates the protein-rich coacervate from its

supernatant, providing a simple mechanism to separate mixtures containing multiple proteins
with different affinities for the coacervating PE.
Coacervation of hyaluronic acid (HA) with model proteins BSA and BLG allowed for
separation of the two component proteins, however a higher degree of selectivity would be
required for purification of mAbs. Coacervation and separation of model proteins BSA and
BLG with HA has been published previously.139 This work focused on construction of phaseboundaries for protein/PE coacervates, allowing for separation of two proteins with similar
pIs by selective phase separation. One challenge in applying this method to the purification
of mAbs, is the high degree of selectivity required in a production environment, as well as
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the development of methods for detecting and quantitating mAb, HA, and model impurity
BSA in the resultant coacervate phase.
Precipitation of mAbs with anionic polyelectrolytes (PEs) has been shown to provide
a limited degree of selectivity for mAb,154, 155, 156, 157, 158 although such methods are not ideal.
The ability to recover active mAb in this way131, 154, 159 depends on the degree to which the
dense phase is solid- versus liquid-like. Extensions to other proteins or conditions are
impeded by the absence of underlying principles for a process often involving complex
kinetics, as well as ambiguity about the exact nature of the dense phase.154, 156, 157 Much of
the literature addresses incremental variations in already established purification “platforms”
among well-established methods for purifying biologics, with results often reported in terms
of log enrichment of mAb, or log depletion of a particular impurity.160, 161 Uncertainties,
resulting from redissolution and quantitation of dense phases, are reduced when the PEprotein interaction leads to a well-defined equilibrium dense liquid, i.e., coacervate.20,
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However, protein/PE coacervation has not hitherto been applied to mAb purification.
In this work we assess the yield and selectivity of the coacervate phase, in order to (1)
establish the suitability of mAb/HA coacervation as a replacement for existing
chromatographic methods, and (2) develop a method for assessing the success of particular
conditions of pH and I in separating mAb from low pI impurities. In this case, BSA was
taken as a model impurity, meant to be an analog to Chinese Hamster Ovary (CHO) host cell
proteins,143 the majority of which have low pIs.138 Coacervates were prepared containing
ternary mixtures of mAb, BSA, and anionic polyelectrolyte HA, and subsequently analyzed
using size-exclusion chromatography (SEC) with multi-angle laser light scattering detection
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(MALLS) and strong cation-exchange chromatography (SCX). While removal of HA is not
explicitly addressed, analytical procedures for its quantitation are demonstrated.

6.3 Experimental Section
Materials. SZE grade sodium hyaluronate (HA), from Shiseido, Lot No. A07A, [η] = 2.6
m3/kg, was used without further purification. A high isoelectric point therapeutic monoclonal
antibody (mAb-A) was obtained from MassBiologics (Mattapan, MA). The mAb-A lot used
for this study was produced in CHO cells and purified over a protein A column. mAb-A has a
molecular weight of 147.6 kDa and a pI of approximately 9.6 (determined by isoelectric
focusing).
Turbidimetry. Turbidity was measured at ambient temperature (T = 21-24 °C) with a
Brinkmann PC800 colorimeter equipped with a 1 cm path length probe, and a 470 nm filter.
For pH titrations, dilute NaOH was used to adjust the pH of mAb (1 mg/mL) and HA (0.1
mg/mL) stock solutions to pH 8, prior to mixing in equal parts. The final concentrations were
0.5 mg/mL MAb-A, and 0.05 mg/mL HA resulting a 10:1 excess of mAb on a weight basis (r
= 10). The solution pH was then lowered by controlled addition of dilute 0.01 N HCl
solution, which was added dropwise from a microburet under constant stirring. Both pH and
transmittance (%T) were recorded after each addition of titrant, allowing sufficient time for
the solution to reach equilibrium. Titration is continued until redissolution of coacervate,
facilitated by loss of HA charge at acidic conditions, is observed at low pH. All stock
solutions were prepared in I = 0.025 M NaCl. Residual buffer from mAb formulation is < 1
mM by dilution. For comparison a control titration is conducted in the absence of HA.
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Preparation of Coacervates. In order to analyze the composition of the coacervate, 40 mL
of sample was prepared using a final mAb concentration of 0.5 mg/mL, r = 10. Samples were
prepared at I = 5, 10, 25, and 50mM NaCl, and pHs 7.9, 7.6, 7.2, and 5.2; corresponding
roughly to the pH of maximum turbidity for each ionic strength. In each case the sample was
adjusted down from a non-interacting pH using dilute (< 0.1 N) HCl, and then centrifuged at
4100 rpm for 60 minutes at T = 21oC. The supernatant was then isolated from the coacervate
(dense phase) by decanting. For SCX analysis the coacervate was then entirely redissolved
in phosphate buffer, containing 1 M NaCl, then diluted to a final salt concentration of 50 mM
NaCl prior to injection.
Size-Exclusion Chromatography. Supernatant from a coacervate prepared at r = 10, I = 25
mM, centrifuged at pH 7.2-7.3, was analyzed directly by size exclusion chromatography
(SEC) using a TOSOH TSK-G3000SWXL column, run on a waters HPLC, using a model 410
differential refractometer (dRI), and an on-line multi-angle laser light scattering (MALLS)
detector (Wyatt Technology). Samples were run in 20 mM phosphate, pH 7, 500 mM NaCl
with < 1% NaN3. For each run samples were injected manually using a 100 uL loop, and run
at a flow rate of 1 mL/min unless otherwise indicated. Using SEC mAb is only partially
resolved from model impurity BSA. The refractive index increments (dn/dc) for protein18
(mAb or BSA), and HA162 were taken to be 0.185, and 0.11 mL/g respectively.
Concentration of HA remaining in the dense phase, and by extension yield of HA in
coacervate, is estimated from dRI signal, using dn/dc to determine the total amount of HA
injected in 100 uL of supernatant.
Cation-Exchange Chromatography. Samples were run on an HPLC 1090LC, using a
diode-array detector (DAD) set to collect traces at 280, 254, 230, and 214 nm
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simultaneously. Standard curves relating peak-height (mAU) at the selected wavelengths
were generating by injecting 100 uL of sample, for a concentration series of mAb-A and
BSA stock solutions (prepared by serial dilution) onto a Pharmacia HR 5/5 strong cationexchange (SCX) column, using a flow rate of 2 mL/min and a step gradient (Buffer A = 0 M
NaCl, pH 8 phosphate / Buffer B = 1 M NaCl, pH 8 phosphate). BSA (negatively charged at
pH 8) elutes prior to increasing % of Buffer B (t = 0.4 min), whereas mAb-A is retained until
a moderately higher %B (t = 2.2 min). Each sample is injected 2X.

6.4 Results & Discussion
Type I titration of mAb with HA (Figure 6.1, black open squares) at an ionic strength
(I) of 0.025 M show that complexation must occur at pH < pI. Solutions of basic protein,
mAb-A, with anionic polyelectrolyte, HA, below the protein’s isoelectric point results in a
stable, non-interacting solution. Once the mixture is lowered to below ca. pH 7.6, the system
abruptly undergoes LLPS (Figure 6.2A). Titration of mAb-A alone (Figure 6.1, red open
circles) shows very minimal pH-dependent self-association, thus the turbidity increase seen
in the presence of HA must result from interactions with the target mAb. Centrifugation of a
large volume of coacervate prepared at pH 7.2 – 7.3 and I = 0.025 M shows the formation of
a characteristic highly viscous, dense-fluid phase (Figure 6.2B).
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Figure 6.1: Turbidimetric pH titration of a mAb/HA mixture (black) from a non-interacting
pH (8.0). As the pH of the solution is lowered, an attractive interaction between mAb and
HA begins, and phase separation occurs. The onset of phase separation is easily and
reproducibly determined by measurements of turbidity. A control experiment is preformed
using mAb alone (red), showing minimal self-association of mAb in this pH range.
Although it will be shown that mAb-A is largely absent from the supernatant,
quantitation of the coacervate dense phases still requires a method for fully resolving the
components of a ternary mixture of mAb, BSA (a model impurity) and HA, which
conveniently elutes near the column void volume. Coacervate prepared at I = 0.025 M, pH
7.2, corresponding to the region of maximum turbidity (Figure 6.1), was analyzed by SEC
with online multi-angle laser light scattering (MALLS) detection (Figure 6.3B). In high salt,
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500mM NaCl, used to screen electrostatic interactions with the column packing, the elution
peak of MAb-A (Figure 6.9) partially overlaps with those of BSA multimers, mainly dimer
(Figure 6.8).
A

B

Figure 6.2: Photograph of a mAb/HA mixture at pH 7.3 (the maximum in turbidity) (A)
prior to centrifugation (B) post-centrifugation, after supernatant has been removed/decanted
and centrifuge tube inverted. Note the dense coacervate phase is a viscous liquid (top).
Supernatants of mAb/BSA/HA coacervates, prepared at ca. 25 mM NaCl, appear to
be selectively depleted of both mAb-A, and higher molecular weight HA chains. Depletion
of HA determined from the dRI trace suggests a coacervate yield of HA ca. 75%. Previous
studies163, 164 have reported the efficiency, of polycation (e.g., PDADMAC), in coacervating
proteins of various pIs, as well as the effect of polyelectrolyte molecular weight (i.e., high

!

94!

molecular weight PEs have a higher affinity for protein).163 This suggests that the ca. 2.5X
reduction, in apparent molecular weight, of the post-coacervation void peak (Figure 6.3B),
relative to an injection of HA alone (Figure 6.7), may be due to selective incorporation of
larger HA chains, into these coacervates.
A

B

Figure 6.3: SEC MALLS, with TOSOH TSK G3000SWXL, using dRI and LS detection.
Peak elution volume assignments Ve = 5.1, 6.8, 7.3, 7.8 and 8.4 mL: HA, BSA trimer, BSA
dimer, MAb-A and BSA monomer, based on solo injections (6.7, 6.8, 6.9). (A) 1:1 mixture
of MAb-A and BSA (B) supernatant of mAb/HA/BSA coacervate prepared at pH 7.3, I =
25mM.
This makes direct determination of protein concentration challenging; however
relative amounts can be determined by comparison with injections of known mixing ratio. A
1:1 mixture of mAb-A and BSA (Figure 6.3A) was run to facilitate comparison with the
more complex ternary mixture. Relative to the starting solution, the supernatant appears, both
from dRI and light scattering traces, to be nearly entirely depleted of mAb-A without any
apparent diminution of the concentration of serum albumin in the supernatant. This suggests
that after centrifugation the majority of mAb is in the coacervate, while model impurity BSA
remains in the supernatant (Figure 6.3B). Direct analysis of the coacervate requires a
separation method that can resolve mAb from low pI model impurities.
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A

B

Figure 6.4: Strong cation-exchange (SCX) chromatograms (254 nm detection) of (A) mAbA and (B) BSA used to construct calibration curves (Figure 6.5A,B). Including those
obtained at 280, 230, and 214 nm.
6.4.1 Ion-Exchange is Able to Resolve BSA from mAb-A
Analytical ion-exchange chromatography allows separation of BSA and mAb, arising
from differences, in protein net charge, and protein charge patches.165 Solo injections of BSA
and mAb-A onto a SCX are separated from each other by several column volumes (Figure
6.4), indicating ease of resolution. Detection at 254 nm minimizes the signal of HA, which
elutes close the elution volume of anionic BSA. To facilitate concentration determination, all
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injection volumes were fixed at 100 uL. All samples were prepared at a fixed I, ca. 50 mM
NaCl, including standards (e.g., serial dilutions of mAb-A and BSA), and redissolved
coacervates.

A

B

Figure 6.5: Injection of mAb-A onto HR 5/5 S-column. Calibration curves constructed for
(A) mAb-A (elutes at 2.2 min, run at 2 mL/min), and (B) BSA (elutes at 0.4 min, run at 2
mL/min). Concentration determination is at four wavelengths (280, 254, 230, and 214 nm).
Detector saturation occurs at peak heights above approximately 2800 mAU (dashed line).
6.4.2 mAb-A/HA Coacervates Are Mostly Free of BSA
As shown in Figure 6.6, removal of BSA from mAb-A occurs following coacervation
at pH ≥ 7.2, and the corresponding ionic strengths I ≤ 25 mM. At lower pH, corresponding to
protein charge states sufficient to overcome screening by high salt, the interaction of BSA
with HA may no longer be negligible. At pH 5.2, the peak intermediate to BSA and mAb
could be assumed to result from direct interactions between mAb-A and BSA, which are
oppositely charged at the pH of redissolution. Comparison with phase boundaries for
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BSA/HA139 suggest that pH 5.2 is close enough to pHφ for BSA with HA that slight
variations in preparation pH may result in coacervates either enriched in, or devoid of, BSA.

Figure 6.6: Strong cation-exchange (SCX) chromatography of redissolved coacervates
prepared at varying ionic strengths and pHs: 5, 10, 25 and 50 mM; and 7.9, 7.6, 7.2 and 5.2.
HA is not detected at 254 nm. The peak at 0.8 minutes corresponds to neither free BSA, nor
to free mAb.
Table 6.1: Yields of mAb-A in coacervates prepared at pH of turbidity maxima

The yield, defined as the mass% of mAb in the coacervate, determined by analysis at
detection wavelengths of λ = 214, 230, 254, and 280 nm. Standard deviations represent
variance between yields calculated using both trials and all four detection wavelengths. 50
mM trial 2 data (from Figure 6, red) was omitted in this analysis.
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6.4.3 Optimizing Selectivity Requires mAb/HA Phase Boundaries
The yield of mAb-A is shown to be highest at I = 25 mM, however this could be
further improved by optimizing either mixing ratio, or pH. For all permutations of I and pH
the yield was shown to be no lower than 60%, and as high as 83% at r = 10 (Table 6.1),
although it is not yet known if this is the optimal mAb:HA ratio. In order to achieve both
optimal yield and selectivity it is clearly necessary to consider the phase boundaries of not
just mAb, but also of the impurity protein(s).

6.5 Conclusions
HA, an injectable anionic polysaccharide, is used to induce selective coacervation,
with the target mAb (e.g., mAb-A). Yields are assessed by, (1) SEC-MALLS analysis of
supernatant, and (2) direct analysis of redissolved coacervate phases, using analytical SCX.
The yield of mAb-A, determined from SCX, is high > 80% by mass, where the concentration
of mAb-A in dense phase is ca. greater than 170 mg/mL. At a single mixing ratio, r = 10, it is
shown that the yield of anionic polyelectrolyte (e.g., HA), in the coacervate, is ca. 75%. The
process of coacervation, for mAb-A/BSA/HA mixtures coacervated at I = 25 mM, involves
selective enrichment of higher molecular weight PE chains in the dense phase, which may
facilitate removal of HA by ultrafiltration. In contrast to methods relying on protein/PE
precipitation, mAb/HA coacervates have been shown to be easily redissolved, by adjustment
of I or pH, allowing recovery of monomeric mAb, and finally providing a high degree of
selectivity (i.e., coacervation of mAb, without any detectible “impurity” proteins). Of all
combinations of preparation conditions (i.e., pH and I) examined, only coacervates prepared
at I = 50 mM NaCl and pH 5.2 show any detectable BSA in the coacervate. Future work will
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involve mapping out optimal conditions (pH, I, and r) for separation of mAb from low pI
“contaminant” proteins, which will be facilitated by construction of a phase boundary,
relating these variables.
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6.7 Supporting Information:

Figure 6.7: SEC-MALLS of HA alone using TSK G3000SWXL at 1 mL/min. Run at pH 7,
500 mM NaCl, 20 mM phosphate, dRI trace (right-axis), calculated MW (open symbols).
Measured dn/dc for HA is 0.11 mL/g, [HA] = 0.25 mg/mL. Ve = 5.1 mL (void) and 5.5 mL.
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Figure 6.8: SEC-MALLS of 2 mg/mL BSA alone at 1 mL/min. Run at pH 7, 500 mM NaCl,
20 mM phosphate. Used dn/dc of 0.185 mL/g. Monomer (Ve = 8.5), dimer (Ve = 7.3 mL),
and trimer (Ve = 6.8 mL) are clearly resolved.

Figure 6.9: SEC-MALS of 1 mg/mL mAb-A alone at 1 mL/min run at pH 7, 500 mM NaCl,
20 mM phosphate. mAb-A has an apparent MW ~ 150 kDa (consistent with monomer MW).
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Figure 6.10: Injection of a mixture of BSA and mAb-A onto a HR 5/5 SCX column. The
peaks are fully resolved.
Table 6.2: Summary of peak heights and peak widths.
A
Injected 250 uL, mixed in 25 mM NaCl

MAb-A
Flow Rate (mL/min)
0.50
0.75
1.00
1.25
1.50
B

Run, 50 mM Phos, pH 8.5, 500 mM NaCl

Using A230
Elution Volume (mL)
8.39
8.24
8.27
7.99
7.95

Injected 250 uL, mixed in 500 mM NaCl

MAb-A
Flow Rate (mL/min)
0.50
0.50
1.50
1.50

Using A230
Elution Volume (mL)
7.45
7.50
7.58
7.58

Peak Width (mL)
0.63
0.65
0.67
0.74
0.71

Tailing?
Yes
No
No
No
No

Run, 50 mM Phos, pH 8.5, 500 mM NaCl

Peak Width (mL)
0.56
0.60
0.79
0.83

Tailing?
Some
Some
No
No

C
Injected 250 uL in 500 mM NaCl

Run, 50 mM Phos, pH 8.5, 500 mM NaCl

BSA
Using A230
Flow Rate (mL/min) Elution Volume (mL)
Peak Width (mL)
Dimer present?
0.50
8.07
0.69
15%
0.50
8.10
0.68
14%
1.50
8.16
0.99
18%
1.50
8.14
1.01
18%
Peak heights and peak widths, reported above, for solutions of mAb-A (A,B) and BSA (C)
alone analyzed by SEC (TSK G3000SWXL) show that even optimal choices of flow rate,
salt, and running buffer will not provide full baseline separation of BSA from mAb.
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CHAPTER 7

SELECTIVE COACERVATION OF MONOCLONAL ANTIBODY WITH ANIONIC
POLYELECTROLYTE HYALURONIC ACID

Daniel Seeman, Alexander J. Malanowski, Rachel Wollacott, and Paul L. Dubin 2015,
(In Prep)

7.1 Abstract
Anionic polysaccharide hyaluronic acid (HA), was used to isolate a target monoclonal
antibody (mAb) from bovine serum albumin (BSA), with a yield as high as 80%, and a
selectivity ratio, S, of ca. 490 for coacervates prepared at pHcBSA < pH < pHφmAb. Values
corresponding to the start of complexation, and coacervation (pHc, pHφ) are reported over a
range of ionic strengths ca. I < 200 mM, above which coacervation is no longer observed.
Finally, yield of mAb is show to correlate with equilibrium turbidity values, obtained from
pH titration.

7.2 Introduction
Selective coacervation of monoclonal antibody with hyaluronic acid (HA) is a
promising replacement for affinity-based capture steps currently associated with purification
of antibodies. Protein A is nearly universally adopted in such industrial purifications, but its
usefulness is limited both by cost and reusability, thus driving the quest for highly-selective,
but concentrating, non-chromatographic approaches. Methods based on polyelectrolyte
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precipitation of antibodies have been shown to provide some degree of selectivity; however
more systematic selection of conditions are needed to provide more control of the yield,
stability, and resolubilization of active antibody, especially given the complex kinetics of
precipitation. On the other hand, protein-polyelectrolye coacervation is an equilibrium
phenomenon, a true liquid−liquid phase separation (LLPS), resulting in enrichment of the
target protein and preservation of its native state. In this study we use an anionic
polysaccharide, HA, to selectively coacervate a target mAb from a mixture containing a lowpI model impurity.
Protein A affinity chromatography is widely adopted as the initial purification step, in
industrial scale purification of monoclonal antibodies (mAbs), but prohibitively high cost
related to the stability and lifetime of the column, limits its usefulness. The high affinity and
selectivity of Protein A chromatography have made it the preferred method for capturing
mAbs from cell culture supernatant (CCS), but the excessive cost of commercial scale
columns, which are on the order of several million dollars, forces the use of smaller columns
and multiple chromatography cycles. Drawbacks of Protein A include (1) the use of low pH
to elute mAb, with possible consequences for its stability, (2) the propensity of protein A
ligand to leach from the resin, requiring subsequent polishing steps to avoid immunogenic
effects of co-eluted Protein A, and (3) the lack of a rigorous cleaning procedure for the resin,
ultimately limiting its reusability. Similar problems have led to a search for nonchromatographic methods for purification of mAbs.
Precipitation of mAbs with anionic polyelectrolytes (PEs) has been shown to provide
a limited degree of selectivity for mAb,154, 155, 156, 157, 158 although such methods are not ideal.
The ability to recover active mAb in this way131, 154, 159 depends on the degree to which the
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dense phase is solid- versus liquid-like. Little attention is paid to the exact conditions (pH, I)
used for phase separation, and the selection of an optimal PE is not systematic.131 Extensions
to other proteins or conditions are impeded by the absence of underlying principles for a
process involving often-complex kinetics, as well as ambiguity about the exact nature of the
dense phase. Such uncertainties are reduced when the PE-protein interaction leads to a
protein-rich well-defined equilibrium dense fluid, i.e., coacervate.
PE/protein complex coacervation is a type of liquid-liquid phase separation (LLPS)
induced by electrostatic attraction between proteins and PEs. The arrangement and density of
protein charges is highly pH and I -dependent, therefore the critical pH166 (pHc) depends on
(1) the charge anisotropy of a particular protein, and (2) the extent to which protein charges
are screened at a particular I. This pHc corresponds to a critical local protein surface charge
density, and may occur when the two macromolecules are of like-charge, ultimately
controlled by the balance between attraction and repulsion.79 Phase separation is defined as
occurring at pHφ, and requires the complexes to reach a condition of local charge
neutrality.167 Centrifugation allows for isolation of a dense, protein-rich phase, typically
referred to as the coacervate phase. For a binary protein mixture, i.e., a mixture of two
separate proteins, the two can be separated on the basis of differing values of pHφ, resulting
in selective enrichment of one the target protein, so long as conditions (pH, I) for phase
separation are mapped out in advance.139 Proper selection of solution conditions will
maximize selectivity and efficiency for optimal purity and yield of mAb, from clarified CHO
cell culture, or Protein-A eluate.
Here, we use hyaluronic acid (HA), an FDA approved cartilage-injectable anionic
polysaccharide, to induce selective coacervation with the target mAb (mAb-A). Coacervation
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occurs due to electrostatic interactions; therefore, pH and ionic strength needs to be
optimized for each additional antibody. Titrations of pH, at different ionic strengths, are used
to determine optimal phase separation conditions that lead to maximal mAb selectivity and
recovery. Comparison with phase boundaries of HA with BSA, used here as a model protein
impurity, allows for determination of optimal separation conditions.

7.3 Experimental Section
Materials. SZE grade sodium hyaluronate, the sodium salt of hyaluronic acid (HA), from
Shiseido, Lot No. A07A, [η] = 2.6 m3/kg, was used without further purification. A high
isoelectric point monoclonal antibody (mAb-A) was obtained from MassBiologics
(Mattapan, MA), with a molecular weight of 147.6 kDa, and a pI of 9.6 as determined by
isoelectric focusing.
Turbidimetry. Turbidity was measured at room temperature (T = 20-25 °C) using a
Brinkmann PC800 colorimeter equipped with a 1 cm path length probe, and a 420 nm filter.
For “type I” titrations, dilute NaOH was used to adjust the pH of mAb (1 mg/mL) and HA
(0.1 mg/mL) stock solutions to the starting pH, prior to mixing in equal parts. The final
concentrations were 0.5 mg/mL MAb-A, and 0.05 mg/mL HA resulting a 10:1 excess of
mAb on a weight basis (r = 10). Solution pH was then lowered by controlled addition of
dilute 0.01 N HCl solution, which was added dropwise from a microburet under constant
stirring. Both pH and transmittance (%T) were recorded after each addition of titrant,
allowing sufficient time for the solution to reach equilibrium. Titration is continued until
redissolution of coacervate, facilitated by loss of HA charge at acidic conditions, is observed
at low pH.
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Preparation of mAb/HA coacervates. In order to analyze the composition of the
coacervate, samples were prepared using 1 g/L mAb-A, 1 g/L BSA, and 0.2 g/L HA, at I =
25 mM, and pHs 4.5, 5.5, and 7.2. Supernatant was removed from the coacervate; the entire
volume of the dense phase was then resuspended in phosphate buffer, containing 1 M NaCl.
Each sample was diluted to a final salt concentration of 50 mM NaCl prior to analysis.
Cation-Exchange chromatography. Samples were run on an Agilent 1100 HPLC, with UV
detection at 230 nm. Standard curves were constructed by injecting standard solutions using a
10 uL loop, onto a Pharmacia HR 5/5 strong cation-exchange (SCX) column, with a flow rate
of 2 mL/min, as previously described (Chapter 6).

7.4 Results & Discussion
7.4.1 Determination of Critical Conditions for MAb-A/HA.
Continuous pH titration experiments of MAb-A/HA and BSA/HA are used to
determine conditions where only mAb should undergo coacervation. Turbidimetric pH
titrations are used to construct a phase boundary for mAb/HA coacervates, the overlap of
which facilitates comparison with previously reported conditions for BSA/HA coacervation
(Figure 7.1). All measured values of mAb/HA pHc are in the region where α = 1, in other
words, where the polyelectrolyte is fully charged and invariant with respect to pH. However,
values of pH obtained at I > 60 mM, fall in the range of 1 > α > 0.5, where the charge on
Φ

HA is reduced as pH is lowered. Furthermore, nearly all pHc and pHφ values are at α < 1 for
BSA, the more acidic of the two proteins. Finally, all critical pH values, pHc and pHφ, are at
α > 0.5, suggesting a unique role of HA charge in controlling electrostatic attractions
between proteins.

!

107!

Figure 7.1: Superimposed phase boundaries of mAb-A/HA (solid) and BSA/HA139 (dashed)
at r = 10. Regions above pHc are non-interacting; soluble complex formation occurs in the
region of pH < pHc and pH > pHφ; and coacervation begins at pH < pHφ. Degree of
ionization, α, of HA is shown in right axis.
7.4.2 Rescaling of Boundary Conditions According to Protein Charge
Scaling of critical values, according to the magnitude of protein charge, allows
comparison between critical conditions for BSA/HA and mAb/HA coacervates. Such
comparisons (Figure 7.2) reveal a nearly linear dependence of pHφ on I1/2; whereas, the more
gradual slope of pHc, near zero at I > 65 mM, is similar to that which is seen for BSA/HA.
Such a dramatic dependence of the pH of phase separation on protein charge, implies
that there may be a feature, unique to mAb, that leads to a different role of net protein charge.
Considering the large size of mAb-A, and as a result, the large number of ionizable groups on
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its surface, it may be possible that the pH of phase separation, pHφ, depends on the local
charge of a particular charge domain within the target mAb, rather than on bulk charge
neutrality.

Figure 7.2: mAb-A/HA (solid) and BSA/HA139 (dashed) at r = 10, normalized to protein
charge. Z < pHc corresponds to non-interacting conditions, where protein charge density is
too low to result in complexation.
At pH < 10, both proteins (mAb and BSA) have similar dependences of charge on pH
(Figure 7.3), suggesting that despite mAb-A having a remarkably higher pI, and larger
number of basic amino acids, the two proteins may have similar charge anisotropy. At highly
basic solution conditions, pH > 11, both proteins converge on similar, net negative, total
charges.
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Figure 7.3: Charge curve(s) for BSA (pI 4.9) and mAb-A (pI 9.6).
7.4.3 Turbidity as a Predictor of Coacervate Yield
A previously developed strong-cation exchange (SCX) based method for quantitating
the amount of protein contained within mAb/HA coacervates, at given conditions of pH and
I, was used to determine the yield of coacervates, prepared at conditions along the above
phase boundary (Figure 7.4). Samples were prepared at I = 25 mM, and pHs 4.5, 5.5, and 7.2.
This allows determination of the total mass of protein in the coacervate, relative to starting
solutions, at pHs corresponding to different points in a turbidimetric titration. The mass
yields of such coacervates are reported in Figure 7.4B, along with turbidity values from a
titration, also at I = 25 mM.
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A

B

Figure 7.4: Determination of the concentration of BSA & mAb in coacervates prepared at
different points in the phase boundary; (A) calibration based on 10uL injections uses peak
heights at 230 nm; (B) %yield of mAb is shown.
7.4.4 Selectivity of HA for mAb
Selectivity arises from the larger enrichment of mAb in the coacervate relative to
BSA. Comparison of mAb/HA and BSA/HA phase boundaries allows us to identify
conditions for selectively coacervating mAb. The selectivity ratio for mAb/HA and BSA/HA
was evaluated at fixed I, at various points in the above phase boundary (Figures 7.1 and 7.2).
The ratio of (mAb:BSA)coac/(mAb:BSA)sup, is used as an indication of the degree of
selectivity of HA for mAb, vs. BSA, in a particular region of pH and I. This selectivity ratio,

!

111!

S, is shown to increase by 15X, between pH 4.5 and 5.5, reaching a final value of S = 490 at
the turbidimetric maximum (Table 7.1).

Table 7.1: Selectivity ratios at pH 4.5, 5.5, 7.2
Selectivity of MAb-A/BSA/HA
coacervation
pH 4.5
(coacervate)
(supernatant)
pH 5.5
(coacervate)
(supernatant)
pH 7.2
(coacervate)
(supernatant)

mAb:BSA
S=9
6.5
0.7
S = 135
54
0.4
S = 490
105
0.2

Selectivity, S, as represented by the ratio of (mAb:BSA)coac/(mAb:BSA)sup. Samples
prepared at I = 25 mM, and pH 4.5, 5.5, and 7.2. The two limiting cases, S = ∞ and S = 1,
would correspond to complete selectivity and no selectivity, respectively.

7.5 Conclusions
Phase boundaries for mAb-A (pI ~ 9.6) are reported here, along with those of model
“impurity” BSA (pI = 4.9). All pHc values, determined for mAb, are in the region of pH
where the ionization state of HA is invariant; on the other hand, values of pH mAb, cross into
Φ

the pH range where 1 > α > 0.5. All critical pH values, pHc and pH , are at α > 0.5,
Φ

suggesting that diminution of HA charge with decreasing pH may be responsible for
narrowing of the coacervation region at higher salt. Conditions for selective coacervation of
mAb-A are deduced from mAb/HA and BSA/HA phase boundaries. Selectivity of mAbA/HA binding was evaluated at constant ionic strength, I = 25 mM, at various points in the
phase boundary. The selectivity, defined as the enhancement of mAb:BSA ratio in the
coacervate, relative to the supernatant, is shown to increase by ca. 15X, from S = 9 to S =
!

112!

135, between pH 4.5 and 5.5, reaching a final value of S = 490 at the point of maximum
turbidity, by which point BSA is nearly undetectable in the coacervate.
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CHAPTER 8

SELF-ASSOCIATION OF MONOCLONAL ANTIBODIES PREDICTING
ANOMALOUS INTERACTIONS WITH STATIONARY PHASE
Daniel Seeman, Paul L. Dubin 2015, (In Prep)

8.1 Abstract
Monoclonal

antibodies

(mAb),

are

shown

to

interact

anomalously

with

chromatography columns when run at low ionic strength (I). Absolute molecular weight
(MW) determination vis-à-vis light scattering detection, suggests that late eluting peaks, are
actually 2X larger in aggregation number than monomeric antibody (monomer MW ca. 150
kDa).

8.2 Introduction
The ability to design and produce novel biologically-based pharmaceuticals such as
monoclonal antibodies (mAbs)131, 140 has surpassed efforts to formulate or stabilize such
proteins; processing mAbs involves moving through a wide range of pHs and buffer
compositions prior to reaching a final formulation condition.131, 141 Stringent FDA guidelines
require a well-defined product, meaning that self-association during processing needs to be
both measurable and predictable.168 Better understanding of pre-formulation mAb proteinprotein interactions could help optimize yield and minimize downstream costs.
Many such quality control measures rely heavily on chromatography-based
analytical methodology,169, 170 for determining whether the final product is comprised entirely
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of intact, monomeric mAb.170, 171 This is complicated by the fact that methods such as sizeexclusion chromatography172 (SEC) are representative of molecular weight173, only so long
as elution of the protein-of-interest is ideal174, 175 (e.g., no direct interaction with stationary
phase176,

177

).

Elution volumes in non-ideal SEC are no longer dependent solely on

hydrodynamic factors,178 i.e., size; in other words, charged species can elute early or late,179,
180

depending how strongly they interact with column packing.172, 181
To that end, non-ideal interactions between a pharmaceutical mAb (mAb-1) are

studied, both in terms of changes in the chromatographic partition coefficient, KSEC, and
apparent molecular weight determined from multi-angle laser light scattering (SEC-MALLS)
detection.

8.3 Experimental Section
Materials. A high isoelectric point therapeutic monoclonal antibody (mAb-1) was obtained
from MassBiologics (Mattapan, MA). The mAb-1 lot used for this study was produced in
CHO cells and purified over a protein A column. mAb-1 has a molecular weight of ca. 150
kDa and a pI of approximately 9.6, as determined by isoelectric focusing.
SEC-MALLS of purified mAb. mAb-1 was analyzed directly by size exclusion
chromatography (SEC) using a TOSOH TSK-G3000SWXL column, run on a waters HPLC,
using a model 410 differential refractometer (dRI), and an on-line multi-angle laser light
scattering (MALLS) detector (Wyatt Technology). Samples were run in 20 mM phosphate,
pH 7, 500 mM NaCl with < 1% NaN3. For each run samples were injected manually using a
100 uL loop, and run at a flow rate of 1 mL/min unless otherwise indicated. The refractive
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index increments (dn/dc) for monoclonal antibody (mAb) was taken as 0.185 mL/g. Samples
were run in 20 mM phosphate, pH 7, and either 500 mM or 200 mM NaCl.

8.4 Results & Discussion

Figure 8.1: SEC of 1 mg/mL mAb-A (A) run at pH 7, 500 mM NaCl, 20 mM phosphate and
(B) pH 7, 200 mM NaCl, 10mM phosphate. Apparent hydrodynamic sizes (Rh) determined
from column calibration.
The elution volume, Ve, in lower salt (i.e., 200 mM NaCl) is delayed (note, extended
x-axis in panel 8.1B) relative to a sample run in 500 mM NaCl. The difference in elution
volume, Ve = 8.2 mL for 500 mM, and Ve = 9.1 for 200 mM, indicates two possibilities;
either (1) the presence of a lower molecular weight species, or a (2) stronger interaction with
the column. Based strictly on typical standard-based column calibration, this would represent
a decrease in hydrodynamic size, from Rh = 5 nm for non-interacting mAb, to 3 nm for the
late-eluting peak.
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Figure 8.2: SEC-MALLS of mAb-A in 500 mM NaCl and 200mM NaCl. MALLS
molecular weights correspond to an aggregation number Nagg ca. 2X monomer for the sample
run in 200 mM salt. Upturn in dRI trace at Ve = 11 mL is due to solvent peak. At early times,
dRI trace has yet to return to baseline after equilibration in low salt buffer.
For this column, the void volume (V0) is 5.1 mL and the total column volume (Vt),
determined by the location of the solvent peak, is 11.2 mL. Thus, it is possible to calculate
chromatographic partition coefficients for samples run at 200 mM and 500 mM NaCl, using
the following expression:

KSEC = (Ve – V0)/(Vt – V0)

(8.1)

For mAb run in 500 mM NaCl, for which it can be assumed that electrostatic
interactions with the column are sufficiently screened as to be non-interacting, KSEC = 0.5;
versus KSEC = 0.66, for the sample run at strongly interacting conditions (i.e., 200 mM).
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Figure 8.3: Chromatographic partition coefficients (KSEC) for sample run at 200 mM as a
function of apparent aggregation number (from MALLS)
It is worth noting that the apparent molecular weight, determined by MALLS, is
higher than that of monomer. The average molecular weight, calculated using the sum of all
multi-angle scattering data collected between Ve = 8 and 10 mL, is ca. 300 kDa, compared to
the 150 kDa monomer of MAb-1. This result strongly implies that not only is this mAb
interacting more strongly with the column; but that such interactions have actually promoted,
or possibly are the product of, dimerization. Furthermore, the shoulder, visible at Ve > 9.5
mL, must correspond to a high aggregation number species, possibly aggregates of mAb, or
maybe clusters similar to those responsible for LLPS of mAb at low temperature (chapter 5).
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8.4 Conclusions
Hydrodynamic based SEC calibration methods, suggest apparent molecular weight
for mAb-1, injected at 200 mM NaCl, that is smaller than that of mAb monomer, where such
delayed elution volumes are typically attributed to the existence of antibody fragments, of
smaller size than monomer. However, MALLS-based, absolute molecular weight
determination, strongly suggests that such late eluting peaks, are actually larger than
monomer, ranging in size from well-defined dimeric mAb, to large aggregates. This suggests
that anomalous hydrodynamic effects, rather than fragmentation or chemical degradation, is
responsible this type of delayed elution.
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CHAPTER 9
CONCLUSIONS & FUTURE OUTLOOK
9.1 Summary and Conclusions
Turbidimetric titrations of aggregation-prone proteins, can provide accurate
measurements of the pH-dependence of the turbidimetric aggregation rate (dτ/dt). This is
used, in the case of model protein BLG, to identify two, predominantly electrostatic, selfassociation steps, and a condition where the macroscopic aggregation rate is equal to zero.
Such a “quench” condition can be exploited to conduct static light scattering (SLS) of
aggregates, which showed the formation of increasingly dense fractal structures over time.
Scattering was also used to elucidate the basic structural unit in a coacervate prepared
from two, oppositely charged, globular proteins. Small-angle neutron scattering (SANS) data
of BLG–LF heteroprotein coacervates (HPCs) is poorly explained by a single, rigidly fixed
BLG2–LF unit, therefore, there must be ongoing rearrangement within a primary unit;
although it seems that the two component proteins retain their globular structures. Rheology
shows that the elasticity of this network of primary units is only weakly dependent on mixing
pH (within the range of pH 5.8 – 6.1), where changes in frequency dependence, must reflect
changes in the dynamics of component proteins.
A high level of nonfreezing water (NFW) was found in several coacervating systems,
with the most significant effect for LF-BLG heteroprotein coacervates. HPCs have the
highest percentage of NFW and a larger ratio of NFW:total macromolecule, which can be
attributed to the existence of a well-defined structural unit, described by LF(BLG2)2 which
enhances protein-water contacts at the expense of protein-contacts.
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Phase separation of monoclonal antibody (mAb) occurs readily at temperatures below
the upper critical solution temperature. It is possible that this could assist in designing mAbs,
optimized for purification efficiency, as well as optimizing stability with respect to
formulation. Solution conditions (pH and I) could be established where LLPS allows for
separation of crude mixtures into a mAb-enhanced, and HCP-depleted, dense phase.
Injectable anionic polysaccharide hyaluronic acid (HA) was used to induce selective
coacervation of mAb, without coacervation of impurity proteins. Yields are assessed by
analysis of supernatant, and also by direct analysis of the coacervate phase. Even at an unoptimized ratio of mAb:HA, over 80% of mAb is shown to go into the coacervate phase. The
concentration of mAb in dense phase was shown to be over 170 mg/mL, similar in magnitude
to that seen for typical protein-PE coacervates (usually ca. 200 mg/mL). The yield of HA in
the coacervate was estimated to be at least 75%, with a concomitant 2X increase in apparent
molecular weight, relative to supernatant. Selective enrichment of higher molecular weight
HA chains may make it easier to remove residual HA by ultrafiltration methods.
Additionally, mAb/HA coacervates are easily redissolved, by adjusting either I or pH,
allowing recovery of intact monomeric mAb.
Phase boundaries for a high pI mAb were generated and compared with those of
BSA. Selectivity ratios for mAb/HA BSA/HA coacervates were shown to increase with
increasing pH, before reaching a final value of S = 490 at the point of maximum turbidity
determined from pH titration. We demonstrate the ability to rapidly determine conditions
useful for the selective coacervation of mAb-A, or for any other mAb, with HA.
Monoclonal antibodies can interact anomalously with the stationary phase of any
chromatography column cable of holding charge. Classical SEC calibration methods imply
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that the molecular weight of such strongly interacting species should be smaller than that of
monomer, and are frequently attributed to the existence of chemically degraded antibody
fragments. However, SEC-MALLS of mAb run in low salt strongly suggest that such late
eluting peaks must have an aggregation number of at least 2X, representing either mAb
dimer, or aggregate.

9.2 Overview
As demonstrated in this work; protein-protein interactions in solutions of a single protein
can either results in open-ended kinetic aggregation (as in the case of model protein BLG); or
if conditions of pH and I are optimal leads to a special form of LLPS (as with mAb);
qualitatively similar to complex coacervation, but comprised of a single self-interacting
macroion. Heteroprotein-interactions reflect the need for a specific geometric ordering
(facilitated by complementarity of protein surface charge); resulting in a highly limited set of
conditions at which two, oppositely charged, proteins can be mixed to form a heteroprotein
coacervate; demonstrated specifically for coacervates of LF and BLG. The conditions under
which a protein and polyelectrolyte can be combined to form a coacervate are far more
expansive; the versatility of this method having been exploited to selectively coacervate a
highly anisotropic protein, monoclonal antibody. Lastly, non-ideal chromatographic
behavior, reflected in delayed elution volumes for highly charged proteins, likely involve
attractive electrostatic interactions, facilitated by protein charge patches; similar to the
interactions that result in complexation on “wrong side” of pI in classical protein containing
coacervates.
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9.3 Outlook
Understanding

the

relationship

between

protein

charge

anisotropy

and

macromolecular phenomenon such as complexation, coacervation, and phase separation, will
allow for greater control over the conditions under which such processes can occur. This
work will aid in applying robust electrostatic modeling of proteins to a number of classical
coacervating systems. Such methods can also be coupled with electrostatically-based Monte
Carlo simulations (Figure 9.1), to facilitate understanding the relationship between charged
proteins, and their polymeric binding partners.

Figure 9.1: Monte Carlo simulations: Antithrombin binding a model Hp pentasaccharide.
Expanded view shows binding at the positive (blue) AT domain with retention of
conformational flexibility.
Much of the work done to improve general understanding of protein phase behavior
can be directly utilized in the production of biologics, specifically monoclonal antibodies
(mAbs). This will help, both in terms of (1) understanding native aggregation of mAbs, and
the various ways this can impair downstream processing and formulations, and (2)
potentially allow for the use of protein charge anisotropy as a design criteria in the
production of stable mAbs.
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Although, the more immediate impact will be in terms of efforts to validate nonchromatographic methods for purification of mAbs. Methods based on liquid-liquid phase
separation have the potential to greatly reduce dependency on the vastly expensive affinity
chromatographies, currently used in the industrial scale production of protein drugs.
Replacing the expensive Protein A chromatography columns used in the production of mAbs,
with one of the non-chromatographic methods evaluated in this work may be able to
significantly reduce the cost of the downstream processing. The success of LLPS-based
purification methods (including coacervation) will depend on finding conditions that (1)
result in phase, via selective enrichment of the lower phase and (2) minimize mAb/HCP
interactions, in order to avoid incidental concentration of contaminants.
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